10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

(Mark One)
x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended December 31, 2013
OR
o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
	For the transition period from  ______________ to ______________

Commission File No. 001-33531

AEROGROW INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

NEVADA	46-0510685
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification Number)

6075 Longbow Drive, Suite 200, Boulder, Colorado	80301
(Address of principal executive offices)	(Zip Code)

(303) 444-7755

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes x No o             

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer   o	Accelerated filer   o
Non-accelerated filer   o (Do not check if smaller reporting company)	Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes o No x

Number of shares of issuer's common stock outstanding as of February 7, 2014:  5,906,634

AeroGrow International, Inc.

TABLE OF CONTENTS

FORM 10-Q REPORT

December 31, 2013

PART I   Financial Information
Item 1.	Financial Statements		3
	Condensed Balance Sheets as of December 31, 2013 (Unaudited) and March 31, 2013		3
	Unaudited Condensed Statements of Operations for the Three and Nine Months Ended December 31, 2013 and 2012 (Unaudited)		4
	Unaudited Condensed Statements of Cash Flows for the Nine Months Ended December 31, 2013 and 2012 (Unaudited)		5
	Notes to the Unaudited Condensed Financial Statements(Unaudited)		7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations		17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		28
Item 4.	Controls and Procedures		28
PART II  Other Information
Item 1.		Legal Proceedings	29
Item 1A.		Risk Factors	29
Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds	29
Item 3.		Defaults Upon Senior Securities	29
Item 4.		Mine Safety Disclosures	29
Item 5.		Other Information	29
Item 6.		Exhibits	30
Signatures			31

PART I - FINANCIAL INFORMATION

Item 1. Condensed Financial Statements

AEROGROW INTERNATIONAL, INC.

CONDENSED BALANCE SHEETS

	December 31, 2013			March 31, 2013
(in thousands, except share and per share data) ASSETS	(Unaudited)			(Derived from Audited Statements)
Current assets
Cash	$	1,274		$	525
Restricted cash		15			42
Accounts receivable, net of allowance for doubtful accounts of $13 and $1 at December 31, 2013 and March 31, 2013, respectively		1,473			173
Other receivables		131			169
Inventory		1,598			1,229
Prepaid expenses and other		223			205
Total current assets		4,714			2,343
Property and equipment, net of accumulated depreciation of  $2,982 and $2,869 at December 31, 2013 and March 31, 2013, respectively		335			266
Other assets
Intangible assets, net of $0 and $135 of accumulated amortization at December 31, 2013 and March 31, 2013, respectively		2			195
Deposits		146			145
Deferred debt issuance costs, net of accumulated amortization of $271 and $255 at December 31, 2013 and March 31, 2013, respectively		7			23
Total other assets		155			363
Total assets	$	5,204		$	2,972
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	756		$	379
Accrued expenses		809			292
Customer deposits		-			157
Deferred rent		4			6
Notes payable		-			518
Notes payable – related party		-			122
Current portion – long term debt		112			900
Derivative warrant liability		595			-
Debt associated with sale of IP		271			-
Total current liabilities		2,547			2,374
Long term debt		-			1,169
Total liabilities		2,547			3,543
Commitments and contingencies
Stockholders' equity (deficit)
Preferred stock, $.001 par value, 20,000,000 shares authorized, 2,649,007 and no shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively		3			-
Common stock, $.001 par value, 750,000,000 shares authorized, 5,906,635 and 5,904,877 shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively		6			6
Additional paid-in capital		79,167			75,427
Stock dividend to be distributed		367			-
Accumulated deficit		(76,886	)		(76,004	)
Total stockholders' equity (deficit)		2,657			(571	)
Total liabilities and stockholders' equity (deficit)	$	5,204		$	2,972

See accompanying notes to the condensed financial statements.

3

AEROGROW INTERNATIONAL, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months ended December 31,						Nine Months ended December 31,
(in thousands, except per share data)	2013			2012			2013			2012
Net revenue	$	4,968		$	2,972		$	6,767			$	5,533
Cost of revenue		2,867			1,665			3,977				2,905
Gross profit		2,101			1,307			2,790				2,628
Operating expenses
Research and development		17			94			72				302
Sales and marketing		1,262			882			2,127				1,765
General and administrative		451			390			1,231				1,407
Total operating expenses	$	1,730		$	1,366		$	3,430			$	3,474
Profit (loss) from operations		371			(59	)		(640	)			(846	)
Other (income) expense, net
Fair value changes in derivative warrant liability		18			-			31				-
Interest expense		14			228			65				441
Interest expense – related party		2			9			8				25
Debt conversion cost		-			-			-				6,648
Other expense (income)		35			1			(498	)			(97	)
Total other expense, net		69			238			(394	)			7,017
Net income (loss)	$	302		$	(297	)	$	(246	)		$	(7,863	)
Less: Deemed dividend on convertible preferred stock		-			-			(268	)			-
Less: Preferred stock dividend		(226	)		-			(367	)			-
Net income (loss) attributable to common shareholders	$	76		$	(297	)	$	(881	)		$	(7,863	)
Net income (loss) per share, basic	$	0.01		$	(0.05	)	$	(0.10	)		$	(1.35	)
Net income (loss) per share, diluted	$	0.01		$	(0.05	)	$	(0.10	)		$	(1.35	)
Weighted average number of common shares outstanding, basic		5,906			5,905			5,905				5,826
Weighted average number of common shares outstanding, diluted		5,992			5,905			5,905				5,826

See accompanying notes to the condensed financial statements.

4

AEROGROW INTERNATIONAL, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended December 31,
(in thousands)	2013			2012
Cash flows from operating activities:
Net (loss)	$	(246	)	$	(7,863	)
Adjustments to reconcile net (loss) to cash (used) provided  by operations:
Issuance of common stock and options under equity compensation plans		176			167
Issuance of common stock warrants		18			-
Depreciation and amortization expense		113			123
Bad debt expense		13			2
Fair value remeasurement of derivative warrant liability		31			-
Accretion of debt associated with sale of intellectual property		(35	)		-
Gain on the forgiveness of debt		(489	)		-
Debt conversion costs associated with inducement		-			3,462
Amortization of debt issuance costs		16			988
Amortization of convertible debentures, beneficial conversion feature		-			1,067
Amortization of convertible debentures, beneficial conversion feature – related party		-			189
Interest expense from warrants issued with convertible debentures		-			955
Interest expense from warrants issued with convertible debentures – related party		-			187
Change in operating assets and liabilities:
(Increase) in accounts receivable		(1,313	)		(271	)
Decrease in other receivable		38			52
(Increase) in inventory		(606	)		(182	)
(Increase) decrease in other current assets		(18	)		151
Increase in accounts payable		377			72
Increase in accrued expenses		517			148
Increase in accrued interest		49			116
Increase  in accrued interest-related party		8			22
(Decrease) increase in customer deposits		(157	)		149
(Decrease) in deferred rent		(2	)		-
Net cash (used) provided by operating activities	$	(1,510	)	$	(466	)
Cash flows from investing activities:
Decrease in restricted cash		27			1
Purchases of equipment		(184	)		(292	)
Patent expenses		-			(10	)
Proceeds from the sale of intellectual property		500			-
Net cash provided (used) by investing activities	$	343		$	(301	)
Cash flows from financing activities:
(Increase) in prepaid debt issuance costs		-			(46	)
Proceeds from notes payable, net		-			1,041
Proceeds from notes payable – related party, net		-			245
Repayments of notes payable		(563	)		(796	)
Repayments of notes payable – related party		(123	)		(272	)
Repayments of long term debt borrowings		(1,243	)		(251	)
Proceeds from the exercise of stock options		2			-
Proceeds from the issuance of preferred stock		4,000			-
Payments for offering costs of preferred stock		(157	)		-
Proceeds from the exercise and issuance of warrants		-			1,181
Net cash provided by financing activities	$	1,916		$	1,102
Net increase in cash		749			335
Cash, beginning of period	$	525			502
Cash, end of period	$	1,274		$	837

See supplemental disclosures below and the accompanying notes to the condensed financial statements.

5

	Nine Months Ended December 31, (in thousands)
Cash paid during the year for:	2013		2012
Interest	$	41	$	119
Income taxes	$	-	$	-
Supplemental disclosure of non-cash investing and financing activities:
Deemed dividend on convertible preferred stock	$	268	$	-
Decrease of inventory associated with debt settlement	$	237	$	-
Fair value of derivative warrant liability	$	564	$	-
Fair value of warrant issue to placement agent	$	108	$	-
Debt associated with sale of intellectual property	$	297	$	-
Dividends accrued on convertible preferred stock	$	367	$	-
Decrease of debt associated with inventory consumption	$	-	$	242
Issuance of common stock in accordance with credit card note	$	-	$	177
Conversion of accrued expenses to common stock	$	-	$	28
Conversion of  note payable to common stock	$	-	$	212
Conversion of  note payable-related party to common stock	$	-	$	129
Conversion of convertible  note to common stock	$	-	$	5,718
Conversion of convertible note accrued interest to common stock	$	-	$	545
Conversion of convertible note-related party to common stock	$	-	$	1,079
Conversion of convertible note-related party accrued interest to common stock	$	-	$	103

6

AEROGROW INTERNATIONAL, INC.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(Unaudited)

1.    Description of the Business

AeroGrow International, Inc. (the “Company," “we,” “AeroGrow,” or “our”) was formed as a Nevada corporation in March 2002. The Company’s principal business is developing, marketing, and distributing advanced indoor aeroponic garden systems designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets worldwide.   The Company manufactures, distributes and markets six different models of its AeroGarden systems in multiple colors, as well as over 40 varieties of seed pod kits and a full line of accessory products through multiple channels including retail distribution, catalogue and direct-to-consumer sales primarily in the United States and Canada, as well as selected countries in Europe, Asia and Australia.

2.    Liquidity and Basis of Presentation

Interim Financial Information

The unaudited interim financial statements of the Company included herein have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim reporting including the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These condensed statements do not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for annual audited financial statements and should be read in conjunction with the Company’s audited financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2013, as filed with the SEC on July 1, 2013.

In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, including normal recurring adjustments, necessary to present fairly the financial position of the Company at December 31, 2013, the results of operations for the three- and nine–month periods ended December 31, 2013 and 2012, and the cash flows for the nine–month periods ended December 31, 2013 and 2012. The results of operations for the three and nine months ended December 31, 2013 are not necessarily indicative of the expected results of operations for the full year or any future period. In this regard, the Company’s business is highly seasonal, with approximately 49.3% of revenues in the fiscal year ended March 31, 2013 (“Fiscal 2013”) occurring in the four consecutive calendar months of October through January.  Furthermore, during the nine-month period ended December 31, 2013, the Company has curtailed sales and incurred additional product and marketing expenses while it cobranded inventory and advertising materials with the Scotts Miracle-Gro trade name.  The balance sheet as of March 31, 2013 is derived from the Company’s audited financial statements.

Sources of funding to meet prospective cash requirements include the Company’s existing cash balances, cash flow from operations, and borrowings under the Company’s debt arrangements.  We may need to seek additional capital, however, to provide a cash reserve against contingencies, address the seasonal nature of our working capital needs, and to enable us to invest further in trying to increase the scale of our business.  There can be no assurance we will be able to raise this additional capital.

Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term.

Net Income (Loss) per Share of Common Stock

The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted earnings per share (“EPS”).  Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS, but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. 

7

The following table presents the computation of basic and diluted net income per share for the three months ended December 31, 2013 (in thousands, except per share amounts):

	December 31, 2013
Net income available to common shareholders	$	76
Basic:
Weighted-average shares outstanding		5,906
Basic net income per share	$	0.01
Diluted:
Weighted-average shares outstanding		5,906
Add: Dilutive potential shares-Stock options		86
Weighted-average shares used in computing diluted net income per share		5,992
Diluted net income per share	$	0.01

Employee stock options to purchase approximately 13,000 shares were outstanding and approximately 528,000 warrants to purchase common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been antidilutive in the periods presented.

Reclassifications

Certain prior year amounts have been reclassified to conform to current year presentation.

Concentrations of Risk

ASC 825-10-50-20requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of December 31, 2013.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.

Customers:

For the three months ended December 31, 2013, two customers, Amazon.com and Costco, represented 39.2% and 10.7% of the Company’s net revenue, respectively. For the three months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 19.3% and 12.8% of the Company’s net revenue, respectively. For the nine months ended December 31, 2013, two customers, Amazon.com and Costco, represented 33.6% and 7.9% of the Company’s net revenue, respectively. For the nine months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 10.4% and 7.9% of the Company’s net revenue, respectively.

Suppliers:

For the three months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $839,000, $707,000, and $205,000, representing 29.3%, 24.7%, and 7.2% of cost of revenue, respectively. For the three months ended December 31, 2012, the Company purchased inventories and other inventory-related items from two suppliers totaling $263,000 and $254,000, representing 15.8% and 15.3% of cost of revenue, respectively. For the nine months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $1.4 million, $992,000, and $270,000 representing 34.4%, 24.9%, and 6.8%, of cost of revenue, respectively. For the nine months ended December 31, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $587,000, $433,000, $392,000, and $334,000 representing 20.2%, 14.9%, 13.5%, and 11.5% of cost of revenue, respectively.

The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on operations.

Accounts Receivable:

As of December 31, 2013, the Company had two customers, Amazon.com and Costco, that represented 62.3% and 23.6% of the Company’s outstanding accounts receivable, respectively.  As of March 31, 2013, the Company one customer, Amazon.com  who represented 61.2% of outstanding accounts receivable.  The Company believes that all receivables from these customers are collectible.

8

Fair Value of Financial Instruments

The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities. ASC 820 provides for a standard definition of fair value to be used in new and existing pronouncements. This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants.  ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.

Level 1 – Quoted prices in active markets for identical assets.

Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations.

Level 3 – Unobservable inputs that are supported by little or no market activity.

The carrying value of financial instruments including receivables and accounts payable, approximates their fair value at December 31, 2013 and March 31, 2013 due to the relatively short-term nature of these instruments. As of December 31, 2013 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.

In conjunction with a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with the subsidiary, “Scotts Miracle-Gro”) on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended December 31, 2013 using a multiple based valuation model.  As of December 31, 2013, the Company measured the warrant at fair value and will continue to do so on a quarterly basis.  As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.

	December 31, 2013 (in thousands)				March 31, 2013 (in thousands)
	Fair Value		Carry Value		Fair Value		Carry Value
Liabilities
Notes payable	$	-	$	-	$	610	$	641
Sale of intellectual property liability		178		271		-		-
Derivative warrant liability		595		595		-		-
Long-term debt		109		112		1,726		2,068
Total	$	882	$	978	$	2,336	$	2,709

Accounts Receivable and Allowance for Doubtful Accounts

The Company sells its products to retailers and consumers. Consumer transactions are primarily paid by credit card.  Retailer sales terms vary by customer, but generally range from net 30 days to net 60 days.  Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company's allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $13,000 and $1,000 at December 31, 2013 and March 31, 2013, respectively.

9

Other Receivables

In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of December 31, 2013 and March 31, 2013, the balance in this reserve account was $131,000 and $169,000, respectively.

Advertising and Production Costs

The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct-response catalogues, and related direct-response advertising costs, in accordance with ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct-to-consumer advertising costs incurred are reported as assets and are amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.  

As the Company has re-entered the retail distribution channel, the Company has expanded its advertising to online gateway and portal advertising, as well as placement in third party catalogues.

Advertising expense for the three and nine months ended December 31, 2013 and December 31, 2012, were as follows:

	Three Months Ended December 31, (in thousands)				Nine Months Ended December 31, (in thousands)
	2013		2012		2013		2012
Direct-to-consumer	$	391	$	534	$	506	$	825
Retail		390		1		393		1
Total advertising expense	$	781	$	535	$	899	$	826

As of December 31, 2013 and March 31, 2013, the Company deferred $6,000 and $4,000, respectively, related to such media and advertising costs.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Deferred advertising and media	$	6	$	4

Inventory

Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at cost.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Finished goods	$	1,124	$	606
Raw materials		474		623
	$	1,598	$	1,229

The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of December 31, 2013 and March 31, 2013, the Company had reserved $332,000 for inventory obsolescence.

10

Revenue Recognition

The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.

The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives.  Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive. As of December 31, 2013 and March 31, 2013, the Company had accrued $236,000 and $43,000, respectively, as its estimate for the foregoing deductions and allowances.

Warranty and Return Reserves

The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold, but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.  Based upon the foregoing, the Company has recorded a reserve for potential future warranty costs of $14,000 and $10,000 as of December 31, 2013 and March 31, 2013, respectively.

The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of December 31, 2013 and March 31, 2013, the Company has recorded a reserve for customer returns of $80,000 and $27,000, respectively.

Recently Issued Accounting Pronouncements

In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. This new guidance will not have a material impact on our financial statements.

3.    Notes Payable, Long Term Debt and Current Portion – Long Term Debt

Refer to the Company’s Annual Report on Form 10-K for the year ended March 31, 2013, as filed with the SEC on July 1, 2013 for a detailed discussion on Notes Payable, Long Term Debt and Current Portion – Long Term Debt.  The following are the changes to our Notes Payable, Long Term Debt and Current Portion – Long Term Debt for the periods presented.

As of December 31, 2013 and March 31, 2013, the outstanding balance of the Company’s note payable and debt, including accrued interest, is as follows:

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Main Power promissory note	$	-	$	1,704
First Western Trust term loan		99		323
Notes Payable –credit card receipts-backed notes		-		640
Pawnee promissory note		13		42
Sale of intellectual property liability (see Note 4)		271		-
Derivative warrant liability (see Note 4)		595		-
Total debt		978		2,709
Less notes payable and current portion – long term debt		978		1,540
Long term debt	$	-	$	1,169

11

Main Power Promissory Note

On June 30, 2009, the Company entered into a Letter Agreement (“Letter Agreement”) with Main Power Electrical Factory, Ltd. (“Main Power”) and executed a Promissory Note.  Pursuant to the terms of the Letter Agreement, Main Power agreed to release the Company from $1.4 million of existing obligations owed by the Company to Main Power in return for the execution of the Promissory Note for the same amount which was amended several times since inception to extend the payment schedule, maturity date and amount owed.   On April 23, 2013, the MainPower Promissory Note outstanding, including all accrued interest, was paid in full for $950,000.

As of April 23, 2013, the Company had consigned approximately $237,000 of inventory with Main Power, all of which was fully reserved for during the three month period ended June 30, 2013. The inventory reserve combined with the payment in full resulted in a net gain of $489,000, which was recognized as other income and expense for the nine months ended December 31, 2013.

First Western Trust Term Loan

On May 21, 2010, the Company, First Western Trust Bank (“FWTB”) and Jack J. Walker, our Chairman, as guarantor, executed a business loan agreement and related promissory note (the “FWTB Term Loan”) for a four-year loan in an initial principal amount of $1.0 million.  The FWTB Term Loan is secured by a lien on our assets and bears interest at a fixed rate of 7.25% per annum.  The Company makes equal monthly payments of principal/interest over the four-year term of the FWTB Term Loan, which has a final maturity date of May 21, 2014.  The terms and conditions of the FWTB Term Loan include limitations on the Company incurring additional debt and paying dividends on our stock without the consent of FWTB.  In the event of a default under the FWTB Term Loan, FWTB has the option to declare the loan immediately due and payable.  

As of December 31, 2013, $99,000 was outstanding under the FWTB Term Loan, including accrued interest, and we were current and in compliance with all terms and conditions.

Notes Payable – 2012 Credit Card Receipts-Backed Notes

On September 14, 2012, the Company closed on the private sale of $1.3 million in Series 2012CC 15% secured promissory notes backed by a portion of the Company’s prospective credit card receipts, (the “2012 Credit Card Notes”) and 128,573 shares of common stock (collectively, the “2012 Credit Card Offering”).  Consideration for the 2012 Credit Card Offering comprised $1.3 million in cash.  After deducting $46,000 of placement agent sales commissions (5% on third-party investors, 3% on Company-referred investors and 0% on investments by officers and directors of the Company) and expenses, net cash proceeds to the Company totaled $1.2 million.   In addition, the Company issued 12,858 shares of common stock to the placement agent as additional sales compensation, representing one share of common stock for every 10 shares issued to investors in the 2012 Credit Card Offering.

The Company used the proceeds from the 2012 Credit Card Offering to invest in advertising and marketing programs to support its direct-to-consumer business, purchase inventory, provide other general working capital, repay $198,000 of the 2011 Credit Card Notes (including accrued interest) and pay commissions and expenses related to the private offering.  

As of December 17, 2013, the remaining balance and accrued interest on the 2012 Credit Card Notes were repaid in full. 

Pawnee Lease Promissory Note

On November 30, 2011, the Company executed a promissory note (the “Lease Promissory Note”) in the principal amount of $116,000 in favor of Pawnee Properties, LLC (“Pawnee”).  The Lease Promissory Note details the terms and conditions pursuant to which the Company will pay to Pawnee past due rent and building operating expenses related to our headquarters lease.  The Lease Promissory Note carries an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter.  

As of December 31, 2013, the outstanding balance of the Lease Promissory Note, including accrued interest, was $13,000 and we were current and in compliance with all terms and conditions.

Debt Associated with Scotts Miracle-Gro Transaction

On April 22, 2013, the Company issued Series B Convertible Preferred Stock to a wholly-owned subsidiary of Scotts Miracle-Gro.  Pursuant to U.S. GAAP, the Company has classified the warrant as a liability at its estimated fair value.  The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period until it is exercised or expires.  The valuation techniques used to determine the fair value of the derivative warrant liability and the terms of the warrant are further explained in Note 4.  As of December 31, 2013 the fair value of the warrant was $595,000.

12

The Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. Since the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of revenue, and because the Company has significant involvement in the generation of its revenue, the excess paid over net book value is classified as debt and is being amortized under the effective interest method.  As of December 31, 2013, $271,000 was recorded as debt on the condensed balance sheets.

4.    Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions

Series B Convertible Preferred Stock and Related Transactions

On April 22, 2013, the Company entered into a Securities Purchase Agreement with Scotts Miracle-Gro.  Pursuant to the Securities Purchase Agreement, Scotts Miracle-Gro acquired 2.6 million shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), and (ii) a warrant to purchase shares of the Company’s common stock (the “Warrant,” as described in greater detail below) for an aggregate purchase price of $4.0 million.  After deducting offering expenses, including commissions and expenses paid to the Company’s advisor, net cash proceeds totaled to $3.8 million.  The Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Promissory Note due to Main Power.  

The Company also issued a warrant to purchase 125,000 shares of the Company’s common stock to the placement agent.  This warrant has an exercise price of $1.54 per share (125% of the average closing price of the Company’s common stock during the five-day period prior to the April 22, 2013 closing date). The value of this warrant was estimated at $108,000, based on the Black-Scholes model with a stock price of $1.30, calculated exercise price of $1.54, expected life of three years, annualized volatility of 117.2% and a discount rate of 0.39%. The value of the warrant was recorded as stock issuance costs.

The Series B Preferred Stock is convertible into 2.6 million shares of the Company’s common stock ($4.0 million divided by a conversion price of $1.51 per share).  The Series B Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Preferred Stock Certificates of Designations).  The Series B Preferred Stock does not have a liquidation preference and shall vote on an “as-converted” basis with the common stock.  The stock dividend will accrue from day to day and will be payable in shares of our common stock within thirty days after the end of each fiscal year end.  The stock dividend issuable will be recorded at the fair market value of our common stock at the end of each quarter in the equity section of the balance sheet.  The corresponding charge will be recorded below net income to arrive at net income available to common shareholders.  The Series B Preferred Stock automatically converts into the Company’s common stock: (i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and the Company’s then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant.

The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a “fully diluted basis” (as defined in the Securities Purchase Agreement), constitute 80% of the Company’s outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.  The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).  In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.  The exercise price of the Warrant shall be equal to the quotient obtained by dividing:

(a)   an amount equal to (i) 1.34 times the trailing twelve months “Net Sales” (which includes sales of the Company’s products by Scotts Miracle-Gro and its affiliates) minus (ii) “Debt Outstanding” net of cash (as such terms are defined in the Warrant),

by

(b)   the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.

13

The Warrant expires on April 22, 2021, the eighth anniversary of the closing date.  The Warrant contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets).  Scotts Miracle-Gro also has the right to participate pro rata, based on Scotts Miracle-Gro’s percentage equity ownership in the Company (assuming the exercise of Scotts Miracle-Gro’s Warrant, but not the exercise of any options outstanding under the Company’s equity compensation plans) in future issuances of the Company’s equity securities.  Upon exercise of the Warrant and demand by Scotts Miracle-Gro, the Company must use its best efforts to file a Registration Statement on Form S-3, or, if the Company is not eligible for Form S-3, on Form S-1 (collectively, the “Registration Statement”), covering the shares of the Company’s common stock covered by the Preferred Stock and the Warrant, within 120 calendar days after receipt of Scotts Miracle-Gro’s demand for registration and shall use its best efforts to cause the Registration Statement to become effective as soon as possible thereafter.

The private offering and sale of the Series B Preferred Stock and Warrant was conducted in reliance upon exemptions from registration requirements under the Securities Act, including, without limitation, those under Regulation D promulgated under the Securities Act.  Scotts Miracle-Gro is an “accredited investor,” as defined in Rule 501 of Regulation D under the Securities Act.  Because the Series B Preferred Stock and the Warrant have not been registered under the Securities Act, they may not be reoffered or resold in the United States absent registration or an applicable exemption from registration.

The foregoing description of the Securities Purchase Agreement, the Certificates of Designations for the Series B Preferred Stock, the Warrant, and the resulting transaction is only a summary, does not purport to be complete, and is qualified in its entirety by reference to the full text of the applicable documents, each of which was included as an exhibit to the Company’s Current Report on Form 8-K, as filed with the SEC on April 23, 2013. The Warrant on the Series B Convertible Preferred Stock was accounted for as a liability at its estimated fair value of $595,000 as of December 31, 2013. The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period it is exercised or expires. The Company calculated the fair value of the Warrant during the quarter ended December 31, 2013 using a multiple based valuation model.

In conjunction with the private offering of Series B Preferred Stock and the Warrant above, the Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Main Power Promissory Note.  Main Power also released the Company’s pledged collateral and the parties agreed to terminate the Letter Agreement and Promissory Note effective as of April 22, 2013, as further described in Note 3.  The Company did not incur any early termination penalties. As of April 23, 2013, there was $237,000 in consignment inventory held by Main Power that was fully reserved for during the three-month period ended June 30, 2013.

In conjunction with the private offering described above, the Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues.

For more details, please refer to Note 8 “Subsequent Events” to the financial statements included in the Company’s Annual Report on Form 10-K, as filed with the SEC on July 1, 2013.

5.    Equity Compensation Plans

On October 17, 2012, the Company implemented a 1-for-100 reverse stock split of its common stock that had previously been approved by stockholders.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock. All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.

For the three months ended December 31, 2013, the Company granted 180,000 options to purchase the Company’s common stock under the Company’s 2005 Equity Compensation Plan (the “2005 Plan”).  For the nine months ended December 31, 2013, the Company granted options to purchase 331,000 options to purchase the Company’s common stock under the 2005 Plan.  For the three and nine months ended December 31, 2012, the Company did not grant any options to purchase the Company’s common stock under the 2005 Plan.

During the three months ended December 31, 2013, options to purchase 75,000 shares of common stock were cancelled or expired, and 2,000 shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the three months ended December 31, 2012, options to purchase 1,000 shares of common stock were cancelled or expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.

14

During the nine months ended December 31, 2013, options to purchase 109,000 shares of common stock were cancelled or expired, and 2,000 shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the nine months ended December 31, 2012, options to purchase 1,000 shares of common stock were cancelled or expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.

As of December 31, 2013, the Company had granted options to purchase 274,000 shares of the Company’s common stock that are unvested and that will result in $316,000 of compensation expense in future periods if fully vested.  

Information regarding all stock options outstanding under the 2005 Plan as of December 31, 2013 is as follows:

		OPTIONS OUTSTANDING								OPTIONS EXERCISABLE
				Weighted-								Weighted-
				average		Weighted-		Aggregate				average		Weighted-		Aggregate
				Remaining		average		Intrinsic				Remaining		average		Intrinsic
Exercise		Options		Contractual		Exercise		Value		Options		Contractual		Exercise		Value
price		(in thousands)		Life (years)		Price		(in thousands)		(in thousands)		Life (years)		Price		(in thousands)
$	1.01		162		4.10	$	1.01				74		4.10	$	1.01
$	1.10		100		4.25	$	1.10				75		4.25	$	1.10
$	1.21		50		4.25	$	1.21				38		4.25	$	1.21
$	2.20		164		4.77	$	2.20				23		4.77	$	1.21
$	2.42		10		4.77	$	2.42				2		4.77	$	1.21
$	7.00		1		1.33	$	7.00				1		1.33	$	7.00
$	8.00		5		1.92	$	8.00				5		1.92	$	8.00
$	12.00		1		0.60	$	12.00				1		0.60	$	12.00
$	13.00		1		0.61	$	13.00				1		0.61	$	13.00
$	14.00		0		1.47	$	14.00				0		1.47	$	14.00
$	18.00		5		0.17	$	18.00				5		0.17	$	18.00
$	20.00		0		1.00	$	20.00				0		1.00	$	20.00
			499		4.30	$	1.77	$	497		225		4.07	$	1.88	$	271

The aggregate intrinsic value in the preceding table represents the difference between the Company’s closing stock price and the exercise price of each in-the-money option on the last trading day of the period presented, which was December 31, 2013.

6.    Income Taxes

The Company follows the guidance in ASC 740, Accounting for Uncertainty in Income Taxes (“ASC 740”) which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements.  This interpretation defines the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.

Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at the end of each period, based on enacted laws and statutory rates applicable to the periods in which the differences are expected to affect taxable income.  Any liability for actual taxes to taxing authorities is recorded as income tax liability. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  A valuation allowance is established against such assets where management is unable to conclude more likely than not that such asset will be realized. As of December 31, 2013 and March 31, 2013, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset balance and the Company has no unrecognized tax benefits related to uncertain tax positions.

7.    Related Party Transactions

See Note 3. Notes Payable, Long Term Debt and Current Portion – Long Term Debt for disclosure of related party transactions.

8.    Stockholders’ Equity

On October 17, 2012, a 1-for-100 reverse stock split of AeroGrow’s common stock became effective.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock.  All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.

15

A summary of the Company’s common stock warrant activity for the period from April 1, 2013 through December 31, 2013 is presented below:

	Warrants Outstanding (in thousands)		Weighted Average Exercise Price		Aggregate Intrinsic Value
Outstanding, April 1, 2013		528	$	22.41	$	0.00
Granted		175		1.70
Exercised		-		-
Expired		0		0.98
Outstanding, December 31, 2013		703	$	17.22	$	0.00

As of December 31, 2013, the Company had the following outstanding warrants to purchase its common stock:

		Weighted Average
Warrants Outstanding (in thousands)		Exercise Price		Remaining Life (years)
	125	$	1.54		4.31
	50	$	2.10		4.77
	394	$	7.00		3.28
	122	$	20.00		1.37
	1	$	25.00		0.77
	3	$	100.00		0.13
	7	$	800.00		0.68
	1	$	825.00		0.68
	703	$	17.22		3.19

As discussed further in Note 4, the Company also issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock.

9.    Subsequent Events

None

16

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The discussion contained herein is for the three and nine months ended December 31, 2013 and December 31, 2012.  The following discussion should be read in conjunction with the financial statements of AeroGrow International, Inc. (the “Company,” “we,” “AeroGrow.” or “our”) and the notes to the financial statements included elsewhere in this Quarterly Report on Form 10-Q for the period ended December 31, 2013 (this “Quarterly Report”). The following discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements that include words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “may,” “will,” or similar expressions that are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Such statements include, but are not limited to, statements regarding our intent, belief, or current expectations regarding our strategies, plans, and objectives, our product release schedules, our ability to design, develop, manufacture, and market products, the ability of our products to achieve or maintain commercial acceptance, our ability to obtain financing necessary to fund our future operations, and our ability to continue as a going concern. Such statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Factors that could cause or contribute to the differences are discussed in this Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations and in Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the year ended March 31, 2013.  Except as required by applicable law or regulation, we undertake no obligation to revise or update any forward-looking statements contained in this Quarterly Report. The information contained in this Quarterly Report is not a complete description of our business or the risks associated with an investment in our common stock. Each reader should carefully review and consider the various disclosures we made in this Quarterly Report and in our other filings with the U.S. Securities and Exchange Commission (“SEC”).

Overview

AeroGrow International, Inc. was formed as a Nevada corporation in March 2002. The Company’s principal business is developing, marketing, and distributing advanced indoor aeroponic garden systems designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets worldwide.  The Company’s principal activities from its formation through March 2006, consisted of product research and development, market research, business planning, and raising the capital necessary to fund these activities. In December 2005, the Company commenced pilot production of its AeroGarden system and, in March 2006, began shipping these systems to retail and catalogue customers. The Company manufactures, distributes and markets six different models of its AeroGarden systems in multiple colors, as well as over 40 varieties of seed pod kits and a full line of accessory products through multiple channels including retail distribution, catalogue and direct-to-consumer sales primarily in the United States and Canada as well as selected countries in Europe, Asia and Australia.

During the fiscal year ended March 31, 2012 (“Fiscal 2012”), we recapitalized our balance sheet.  Specifically, we restructured the amounts and payment timing of certain of our accounts payable, issued $1.6 million in short-term working capital debt,  restructured the payment schedule for a $2.1 million note payable to a supplier, and received approval from our shareholders and affected creditors to convert our Series A Convertible Preferred Stock and Subordinated Secured Convertible Notes into common stock. The conversions of our convertible securities were completed in April 2012, the first month the year ended March 31, 2013 (“Fiscal 2013”).  In addition, during the first quarter of Fiscal 2013, we offered our warrant holders the opportunity to exercise their warrants at a reduced price, resulting in $1.6 million of new common equity capital from warrant exercises.

We entered into a Securities Purchase Agreement and strategic alliance in April 2013 with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with its subsidiary, “Scotts Miracle-Gro”). Pursuant to the Securities Purchase Agreement, we issued (i) 2.6 million shares of Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock); and (ii) a warrant to purchase shares of our common stock for an aggregate purchase price of $4.0 million.  In addition, as part of the strategic alliance, we entered into several other agreements with Scotts Miracle-Gro, including: (i) an Intellectual Property Sale Agreement; (ii) a Technology Licensing Agreement; (iii) a Brand License Agreement; and (iv) a Supply Chain Management Agreement.

17

Pursuant to the Intellectual Property Agreement, we agreed to sell all intellectual property associated with our hydroponic products (the “Hydroponic IP”), other than the AeroGrow and AeroGarden trademarks, free and clear of all encumbrances, to Scotts Miracle-Gro for $500,000.  Scotts Miracle-Gro has the right to use the AeroGrow and AeroGarden trademarks in connection with the sale of products incorporating the Hydroponic IP.  In addition to the working capital infusion of approximately $4.5 million from the Securities Purchase Agreement and Intellectual Property Sale Agreement, the strategic alliance affords us the use of the globally recognized and highly trusted Miracle-Gro brand name.  We believe that the strategic alliance also gives Scotts Miracle-Gro an entry into the burgeoning indoor gardening market, while providing AeroGrow a broad base of support in marketing, distribution, supply chain logistics, R&D, and sourcing.  We intend to use our strategic alliance with Scotts Miracle-Gro to re-establish our presence in the retail and international sales channels.

Results of Operations

Three Months Ended December 31, 2013 and December 31, 2012

Summary Overview

For the three months ended December 31, 2013, we generated $5.0 million of total revenue, an increase of 67.1%, or $2.0 million, relative to the same period in the prior year.  Due to our renewed focus on increasing retail distribution, retail sales increased 289.2% to $2.4 million.  Direct-to-consumer sales increased 8.2%, to $2.5 million, reflecting new products, efficient advertising and joint marketing programs with The Scotts Miracle-Gro Company.  Sales to international distributors decreased by 25.8% to $17,000 in the three months ended December 31, 2013 relative to the same period in the prior year.

During the three months ended December 31, 2013, we spent $781,000 in advertising expenditures to support our direct-to-consumer and retail channels, a 46.0% year-over-year increase compared to the same period in Fiscal 2013. These expenditures were divided as follows:

·   Direct-to-consumer advertising decreased to $391,000 from $534,000 for the three months ended December 31, 2013 and December 31, 2012, respectively.  Efficiency, as measured by dollars of direct-to-consumer sales per dollar of related advertising expense, increased to $6.43 or 48.1% for the three months ended December 31, 2013, as compared to $4.35 for the same period in Fiscal 2013.

·   Retail advertising increased to $390,000 from $1,000 for the three months ended December 31, 2013 and December 31, 2012, respectively, as the Company focused on driving product awareness on behalf of our retail partners.

For the three months ended December 31, 2013, AeroGarden sales represented 83.8% of total revenue, as compared to 62.1% in the prior year period.  This percentage increase, on a product line basis, was attributable to increased retail distribution, which tends initially to favor garden sales over seed pod kit or accessory sales, and to the launch of our new AeroGarden ULTRA LED during the high demand holiday season.  Seed pod kit and accessory sales decreased as a percent of the total to 16.2% from 37.9% in the prior year period due largely to the size of the increase in garden sales.

Our gross margin for the three months ended December 31, 2013 was 42.3%, down from 44.0% in the prior year period, as we shifted our revenue mix from higher margin direct-to-consumer customers and seed pod kit sales to lower margin wholesale sales to retailers, international distributors and AeroGarden sales. Our gross margin is also negatively affected by brand and intellectual property royalty fees associated with our strategic alliance with Scotts Miracle-Gro, which we believe will result in expanded sales outlets and higher sales volume.

In aggregate, our total operating expenses increased 26.6%, or $364,000, year-over-year, principally because we spent $380,000 more in advertising with our larger retailers.  This increase was slightly offset by reduced spending in research and development. As a result of increased sales, our operating profit was $371,000 for the three months ended December 31, 2013, as compared to an operating loss of $59,000 in the prior year period.

Net other income and expense for the three months ended December 31, 2013 totaled $69,000, as compared to net other expense of $238,000 in the prior year period.  The net other expense in the current period includes $18,000 of expense relating to the fair value revaluation of the warrant held by Scotts Miracle-Gro.  The net other expense in the prior year period included $108,000 in non-cash amortization expense related to short-term promissory notes that were issued in September 2012.

Net income for the three months ended December 31, 2013 was $302,000, as compared to the $297,000 loss a year earlier.  The net profit reflected the higher retail sales attributable to the popularity of cobranded Scotts Miracle-Gro products and an increased advertising dollars spent in that channel.

18

The following table sets forth, as a percentage of sales, our financial results for the three months ended December 31, 2013 and the three months ended December 31, 2012:

	Three Months Ended December 31, (in thousands)
	2013			2012
Net revenue
Direct-to-consumer		50.5	%		78.1	%
Retail		49.1	%		21.1	%
International		0.4	%		0.8	%
Total net revenue		100.0	%		100.0	%
Cost of revenue		57.7	%		56.0	%
Gross profit		42.3	%		44.0	%
Operating expenses
Research and development		0.3	%		3.2	%
Sales and marketing		25.4	%		29.7	%
General and administrative		9.1	%		13.1	%
Total operating expenses		34.8	%		46.0	%
Profit (loss) from operations		7.5	%		(2.0	)%

Revenue

For the three months ended December 31, 2013, revenue totaled $5.0 million, a year-over-year increase of 67.1% or $2.0 million, from the three months ended December 31, 2012.

	Three Months Ended December 31, (in thousands)
Net revenue	2013		2012
Direct-to-consumer	$	2,514	$	2,323
Retail		2,437		626
International		17		23
Total	$	4,968	$	2,972

Direct-to-consumer sales for the three months ended December 31, 2013 totaled $2.5 million, up $191,000, or 8.2%, from the prior year period.  The increase in direct-to-consumer channels was caused by our introduction of our new ULTRA LED product and the availability of the various cobranded AeroGardens. We also experienced an increase in the direct-to-consumer database for the first time in 19 months. We define this “active consumer” database as the number of customers that have made a purchase within the previous 12 months.  This number is calculated monthly at the first of each month.

Sales to retailer customers for the three months ended December 31, 2013 totaled $2.4 million, up $1.8 million, or 289.2%, principally reflecting sales to newly acquired retail accounts such as Costco, Home Shopping Network, The Home Depot and Target, as well as growth in the existing Amazon.com account. We spent $390,000 in advertising dollars in the retail distribution channel, primarily in online gateway and portal advertising, as well as third party catalogues.

International sales for the three months ended December 31, 2013 totaled $17,000, down $6,000, or 25.8%, from the same period in the prior fiscal year. Sales in both periods principally reflect the timing of reorders from existing international distributors only.

19

Our products consist of AeroGardens, and seed pod kits and accessories.  A summary of the sales of these two product categories for the three months ended December 31, 2013 and December 31, 2012 is as follows:

	Three Months Ended December 31, (in thousands)
	2013			2012
Product revenue
AeroGardens	$	4,165		$	1,846
Seed pod kits and accessories		803			1,126
Total	$	4,968		$	2,972
% of total revenue
AeroGardens		83.8	%		62.1	%
Seed pod kits and accessories		16.2	%		37.9	%
Total		100.0	%		100.0	%

AeroGarden sales increased $2.3 million, or 125.5%, from the prior year period, reflecting increased retail channel sales and an increase in the portion of our direct-to-consumer marketing activity dedicated to prospecting for new customers, who are more likely to purchase the AeroGardens that have been co-branded after our alliance with Scotts Miracle-Gro.  The decrease in seed pod kit and accessory sales, which declined by $323,000, or 28.7%, principally reflects the focus on acquiring new customers and is expected to increase as new purchasers of gardens this year purchase seed pod kits and accessories in coming months and years.  For the three months ended December 31, 2013, sales of seed pod kits and accessories represented 16.2% of total revenue, as compared to 37.9% in the prior year period.

Cost of Revenue

Cost of revenue for the three months ended December 31, 2013 totaled $2.9 million, an increase of $1.2 million, or 72.1%, from the three months ended December 31, 2013.  Cost of revenue includes product costs for purchased and manufactured products, freight costs for inbound freight from manufacturers, costs related to warehousing and the shipping of products to customers, credit card processing fees for direct sales, and duties and customs applicable to imported products.   As a percent of total revenue, cost of revenue represented 57.7% of revenue as compared to 56.0% for the quarter ended December 31, 2012.  The increase in costs as a percent of revenue reflected brand and intellectual property royalty fees associated with our strategic alliance with Scotts Miracle-Gro, the shift of our revenue mix from higher margin direct-to-consumer customers and seed pod kit sales to lower margin retailers, and AeroGarden sales.

Gross Margin

Our gross margin varies based upon the factors impacting net revenue and cost of revenue as discussed above, as well as the mix of our revenue that comes from the retail, direct-to-consumer, and international channels.  In a direct-to-consumer sale, we recognize as revenue the full consumer purchase price for the product.  In retail and international sales, by comparison, we recognize as revenue the wholesale price that we charge to the retailer or international distributor.  Media costs associated with direct sales are included in sales and marketing expenses.  For international sales, margins are structured based on the distributor purchasing products by letter of credit or cash in advance, terms with the distributor bearing all of the marketing and distribution costs within its territory.  As a result, international sales generally have lower gross margins than domestic retail sales.  The gross margin for the quarter ended December 31, 2013 was 42.3% as compared to 44.0% for the quarter ended December 31, 2012.  The decrease in our gross margin was primarily attributable to the increased percentage of sales to retailers, primarily Amazon.com and Costco, as well as expenses associated with inventory cobranding and payment of intellectual property royalty fees associated with our strategic alliance with Scotts Miracle-Gro.

Sales and Marketing

Sales and marketing costs for the three months ended December 31, 2013 totaled $1.3 million, as compared to $882,000 for the three months ended December 31, 2012, an increase of 43.1%, or $380,000.  Sales and marketing costs include all costs associated with the marketing, sales, operations, customer support, and sales order processing for our products, and consisted of the following:

	Three Months Ended December 31, (in thousands)
	2013		2012
Advertising	$	781	$	535
Personnel		330		261
Sales commissions		18		24
Trade Shows		5		-
Other		128		62
	$	1,262	$	882

20

Advertising expense is composed primarily of catalogue development, production, printing, and postage costs, web media expenses for search and affiliate web marketing programs, and the cost of developing and employing other forms of advertising.  Each is a key component of our integrated marketing strategy because it helps build consumer awareness and demand for our products in the retailer and direct-to-consumer sales channels.   Total advertising expense was $781,000 for the quarter ended December 31, 2013, a year-over-year increase of 46.0%, or $246,000, primarily because we participated in advertising programs with our on-line retail distribution channel to support various promotional programs to increase product awareness of our cobranded product line with the Miracle-Gro AeroGarden trade name. Additionally, advertising costs related to our newly acquired retail accounts have increased from $1,000 to $391,000 in the current period.

Sales and marketing personnel costs include salaries, payroll taxes, employee benefits and other payroll costs for our sales, operations, customer service, graphics and marketing departments.  For the three months ended December 31, 2013, personnel costs for sales and marketing were $330,000, up $69,000 or 26.4% from the three months ended December 31, 2012.   The increase reflected increased headcount necessary to cobrand and reintroduce our products into the retail channels and related payroll and stock option expenses.

Other marketing expenses increased year-over-year as a result of a public relations program that was initiated during the current year.

General and Administrative

General and administrative costs for the three months ended December 31, 2013 totaled $451,000, as compared to $390,000 for the three months ended December 31, 2012, an increase of 15.6%, or $61,000. The increase was attributable to expenses associated with recent grants of stock options, as well as recruiting expenses to attract and replace certain personnel. 

Research and Development

Research and development costs for the quarter ended December 31, 2013 totaled $17,000, a decrease of $77,000 from the quarter ended December 31, 2012.  The decrease principally reflected expenses related to design and consulting service expenses we incurred to support new product development activities in prior year.

Operating Income (Loss) and EBITDA

Our operating income for the three months ended December 31, 2013 was $371,000, an increase of $430,000 over the $59,000 operating loss for the three months ended December 31, 2012, which was attributable to increased sales in both the retail distribution and direct-to consumer channels.

As a non-U.S. GAAP measure of our operating performance, we track earnings before interest, taxes, depreciation and amortization (“EBITDA”) as an indicator of our ability to generate cash, which we define as operating income or loss excluding the non-cash depreciation, amortization, change in derivative warrant liability, Scott’s Miracle-Gro IP royalty and branding, and stock based compensation expense incurred during the period.  As calculated in the table below, our EBITDA for the quarter ended December 31, 2013 totaled $685,000, which was $650,000 higher than the $35,000 of EBITDA recorded during the prior year quarter.

	Three Months Ended December 31, (in thousands)
	2013		2012
Operating profit (loss)	$	371	$	(59	)
Add back non-cash items:
Depreciation		42		49
Amortization		-		3
Stock based compensation		89		42
Common stock warrant expense		18		-
Scott’s Miracle-Gro IP royalty and branding license		165		-
Total non-cash items		314		94
EBITDA	$	685	$	35

The U.S. GAAP measure most directly comparable to EBITDA is net earnings. The non-U.S. GAAP financial measure of EBITDA should not be considered as an alternative to net earnings. EBITDA is not a presentation made in accordance with U.S. GAAP and has important limitations as an analytical tool. EBITDA should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Because EBITDA excludes some, but not all, items that affect net earnings and is defined differently by different companies, our definition of EBITDA may not be comparable to similarly titled measures of other companies.

21

Net Income and Loss

For the three months ended December 31, 2013, we recorded net income of $302,000, a 599,000 increase over the $297,000 net loss for the three months ended December 31, 2012.  The increase in the net income reflected the increased sales due to reintroduction into the retail channels, the positive impact of having sufficient inventory levels during the peak selling season, and the product launch of our new AeroGarden ULTRA - LED.

Nine Months Ended December 31, 2013 and December 31, 2012

Summary Overview

For the nine months ended December 31, 2013, total revenue of $6.8 million was up 22.3%, or $1.2 million, relative to the same period in the prior year.  Sales in our direct-to-consumer channels were down, by 19.8%, or $945,000.  The decline was primarily due to significant out of stock situations faced in the first six months of the year as we drew down inventory in advance of our cobranding efforts.  The decline was more than offset by increased sales in our retail channels which were up $2.1 million or 307.2%, primarily due to sales to retailers, including sales to Amazon.com, which began in November 2012, and newly acquired retail accounts such as Costco, Home Shopping Network, The Home Depot and Target.  Sales to international distributors increased by 114.5% to $102,000 in the nine months ended December 31, 2013 relative to the same period in the prior year. This increase is exclusively attributable to reorders from existing customers.

During the nine months ended December 31, 2013, we spent $899,000 in advertising expenditures to support our direct-to-consumer and retail channels, a 8.8% year-over-year increase compared to the same period in Fiscal 2013.  These expenditures were divided as follows:

·   Direct-to-consumer advertising decreased to $506,000 from $825,000 for the nine months ended December 31,2013 and December 31, 2012, respectively.  Efficiency, as measure by dollars of direct-to-consumer sales per dollar of related advertising expense, increased to $7.55 or 30.8% for the nine months ended December 31, 2013, as compared to $5.78 for the same period in Fiscal 2013.

·   Retail advertising increased to $393,000 from $1,000 for the nine months ended December 31, 2013 and December 31, 2012, respectively, as the Company focused on driving product awareness on behalf of our retail partners.

Additionally, for the nine months ended we controlled our overall marketing spending due to the lack of inventory in the first six months as we cobranded our product line with the Miracle-Gro trade name and increased our advertising spend in the remaining three months as we introduced the high end AeroGarden ULTRA LED, which were well received.

For the nine months ended December 31, 2013, AeroGarden sales increased by 82.1% and represented 74.7% of total revenue, as compared to 50.2% in the prior year period.  This percentage increase, on a product line basis was attributable to increased levels of co-branded Scotts Miracle-Gro inventory during the peak holiday season, new retail accounts and the launch of the new ULTRA LED AeroGarden.  Seed pod kit and accessory sales fell by 37.9% year-over-year, and dropped as a percent of the total to 25.3% from 49.8% in the prior year period.

Our gross margin for the nine months ended December 31, 2013 was 41.2%, as compared to 47.5% during the prior year period, as we shifted our revenue mix from higher margin direct-to-consumer customers and seed pod kit sales to lower margin sales to retailers, international distributors and AeroGarden sales. Our gross margin is also negatively affected by brand and intellectual property royalty fees associated with our strategic alliance with Scotts Miracle-Gro, which we believe will result in expanded sales outlets and lower gross margins.

In aggregate, our total operating expenses decreased 1.3%, or $45,000, year-over-year, principally because we: (i) did not replace our Chief Financial Officer who resigned in April 2013, (ii) incurred less legal, corporate governance and regulatory costs, and (iii) conducted less research and development cost after we introduced the new AeroGrow ULTRA product in the third quarter of Fiscal 2013.

As a result of higher sales, our operating loss decreased by $206,000 to $640,000 for the nine months ended December 31, 2013, from $846,000 in the prior year period.

22

Other income and expense for the nine months ended December 31, 2013 totaled to a net other income of $394,000, as compared to net other expense of $7.0 million in the prior year period.  The net other income in the current year period included $489,000 of income attributable to the repayment and settlement of the Main Power note.  The net other expense in the prior year period included $6.6 million in non-recurring, non-cash debt conversion costs, $80,000 in non-recurring gains relating to adjustments in estimates of certain accounts payable accounts, and $131,000 in non-cash amortization expense related to short-term promissory notes issued in September 2012.  

The net loss for the nine months ended December 31, 2013 was $246,000, which was less than the $7.9 million loss in the prior year principally because the gain on the settlement on the Main Power Note, and the non-cash charges that resulted from the conversion of all our outstanding convertible debt into common stock during the prior period, partially offset by higher inventory cobranding expenses in the current year period.

The following table sets forth, as a percentage of sales, our financial results for the nine months ended December 31, 2013 and the nine months ended December 31, 2012:

	Nine Months Ended December 31,
	2013			2012
Net revenue
Direct-to-consumer		56.5	%		86.2	%
Retail		40.7	%		12.2	%
International		2.8	%		1.6	%
Total net revenue		100.0	%		100.0	%
Cost of revenue		58.8	%		52.5	%
Gross profit		41.2	%		47.5	%
Operating expenses
Research and development		1.1	%		5.5	%
Sales and marketing		31.4	%		31.9	%
General and administrative		18.2	%		25.4	%
Total operating expenses		50.7	%		62.8	%
Loss from operations		(9.5	)%		(15.3	)%

Revenue

For the nine months ended December 31, 2013, revenue totaled $6.8 million, a year-over-year increase of 22.3%, or $1.2 million, from the nine months ended December 31, 2012.

	Nine Months Ended December 31, (in thousands)
Net Revenue	2013		2012
Direct-to-consumer	$	3,823	$	4,768
Retail		2,754		676
International		190		89
Total	$	6,767	$	5,533

Direct-to-consumer sales for the nine months ended December 31, 2013 totaled $3.8 million, down $945,000, or 19.8%, from the prior year period.  The decline in sales to direct-to-consumer channels was caused by the aging of our direct-to-consumer customer file, a decrease in direct-to-consumer advertising, our renewed focus on the retail marketing channel after we entered the strategic alliance with Scotts Miracle-Gro, and lower inventory levels, as we began cobranding our products with the Scotts Miracle-Gro trade name.Although direct-to-consumer sales did decline during the nine-month period ended December 31, 2013, we did experience an increase in such sales in December 2013, for the first time since May 2012.

Sales to retailer customers for the nine months ended December 31, 2013 totaled $2.8 million, up $2.1 million, or 307.2%, from the prior-year period, principally reflecting increased sales to newly acquired retail accounts, particularly Amazon.com and Costco.

International sales for the nine months ended December 31, 2013 totaled $190,000, up $101,000.  Sales in both periods principally reflect the timing of reorders from existing international distributors only.

23

Our products consist of AeroGardens, and seed pod kits and accessories.  A summary of the sales of these two product categories for the nine months ended December 31, 2013 and December 31, 2012 is as follows:

	Nine Months Ended December 31, (in thousands)
	2013			2012
Product Revenue
AeroGardens	$	5,057		$	2,777
Seed pod kits and accessories		1,710			2,756
Total	$	6,767		$	5,533
% of Total Revenue
AeroGardens		74.7	%		50.2	%
Seed pod kits and accessories		25.3	%		49.8	%
Total		100.0	%		100.0	%

AeroGarden sales increased $2.3 million, or 82.1%, from the prior year period, principally because: (i) the increase in sales to retailers in the fiscal third quarter, (ii) the increase in direct-to-consumer prospecting activity which tends to generate a higher mix of AeroGarden sales, (iii) the launch of the new AeroGarden ULTRA LED model, and (iv) the cobranding of our products with the Miracle-Gro AeroGarden name.  Sales of seed pod kits and accessories decreased $1.0 million, or 37.9%, reflecting a decrease in direct-to-consumer sales.  For the nine months ended December 31, 2013, sales of seed pod kits and accessories represented 25.3% of total revenue, as compared to 49.8% in the prior year period.

Cost of Revenue

Cost of revenue for the nine months ended December 31, 2013 totaled $4.0 million, an increase of $1.1 million, or 36.9%, from the nine months ended December 31, 2012.  Cost of revenue includes product costs for purchased and manufactured products, freight costs for inbound freight from manufacturers, costs related to warehousing and the shipping of products to customers, credit card processing fees for direct sales, and duties and customs applicable to imported products. As a percent of total revenue, cost of revenue represented 58.8% of revenue, as compared to 52.5% during the nine months ended December 31, 2012.  The increase in costs as a percent of revenue reflected brand and intellectual property royalty fees associated with our strategic alliance with Scotts Miracle-Gro, the shift of our revenue mix from higher margin direct-to-consumer customers and seed pod kit sales to lower margin retailers, international distributors and AeroGarden sales.

Gross Margin

Our gross margin varies based upon the factors affecting net revenue and cost of revenue as discussed above, as well as the mix of our revenue that comes from the retail, direct-to-consumer, and international channels.  In a direct-to-consumer sale, we recognize as revenue the full consumer purchase price for the product.  In retail and international sales, by comparison, we recognize as revenue the wholesale price that we charge to the retailer or international distributor.  Media costs associated with direct sales are included in sales and marketing expenses.  For international sales, margins are structured based on the distributor purchasing products by letter of credit or cash in advance terms, with the distributor bearing all of the marketing and distribution costs within its territory.  As a result, international sales generally have lower gross margins than domestic retail sales.  The gross margin for the nine months ended December 31, 2013 was 41.2% as compared to 47.5% for the nine months ended December 31, 2012.  The decrease in our gross margin was primarily attributable to the increased percentage of sales to retailers, primarily Amazon.com and Costco, cost associated with inventory cobranding and the payment of intellectual property royalty fees associated with our strategic alliance with Scotts Miracle-Gro, and increased international sales.

Sales and Marketing

Sales and marketing costs for the nine months ended December 31, 2013 totaled $2.1 million, as compared to $1.8 million for the nine months ended December 31, 2012, an increase of 20.5%, or $361,000.  Sales and marketing costs include all costs associated with the marketing, sales, operations, customer support, and sales order processing for our products, and consisted of the following:

	Nine Months Ended December 31, (in thousands)
	2013		2012
Advertising	$	899	$	826
Personnel		878		739
Sales commissions		16		31
Trade shows		6		2
Other		328		167
	$	2,127	$	1,765

24

Advertising expense totaled $899,000 for the nine months ended December 31, 2013, a year-over-year increase of 8.9%, or $73,000, primarily because of our increased focus in retail advertising, partially offset by lower catalogue mailing expenses during the current year period.

Sales and marketing personnel costs include salaries, payroll taxes, employee benefits and other payroll costs for our sales, operations, customer service, graphics and marketing departments.  For the nine months ended December 31, 2013, personnel costs for sales and marketing were $878,000, up from $739,000 for the nine months ended December 31, 2012, an increase of 18.9%.  The increase reflected increased headcount required to cobrand our marketing literature and packaging with the Miracle-Gro AeroGarden name and the additional support required to reintroduce our products into the retail channels.

Other marketing expenses increased year-over-year because of increases in a variety of spending categories, including a public relations program and increased travel related to reintroduction to the retail channel.

General and Administrative

General and administrative costs for the nine months ended December 31, 2013 totaled $1.2 million, as compared to $1.4 million for the nine months ended December 31, 2012, a decrease of 12.5%, or $176,000.  The decrease is the result of not replacing the Chief Financial Officer, who resigned in April of 2013, and reduction in legal, corporate governance and regulatory costs that were associated with the conversion of our convertible debt into equity in the prior year period.

Research and Development

Research and development costs for the nine months ended December 31, 2013 totaled $72,000, a decrease of 76.2%, or $230,000, from the nine months ended December 31, 2012.  The decrease principally reflects expenses related to design and consulting expenses we incurred in the prior year period to support new product activities (primarily the AeroGarden ULTRA which was introduced in the third quarter of Fiscal 2013).

Operating Loss and EBITDA

Our operating loss for the nine months ended December 31, 2013 was $640,000, a decrease of $206,000 from the operating loss of $846,000 for the nine months ended December 31, 2012.  The decreased loss reflected higher sales and higher cost of revenue expenses, as discussed in greater detail above.

As a non-U.S. GAAP measure of our operating performance, we track earnings before interest, taxes, depreciation and amortization (“EBITDA”) as an indicator of our ability to generate cash, which we define as Operating Profit or Loss excluding the non-cash depreciation, amortization, change in derivative warrant liability, Scotts Miracle-Gro IP royalty and branding, and stock based compensation expense incurred during the period.  As calculated in the table below, our EBITDA loss for the nine months ended December 31, 2013 totaled $121,000, as compared to an EBITDA loss of $556,000 recognized during the prior year period.

	Nine Months Ended December 31, (in thousands)
	2013			2012
Operating loss	$	(640	)	$	(846	)
Add back non-cash items:
Depreciation		113			112
Amortization		-			11
Stock based compensation		176			167
Common stock warrant expense		18			-
Scotts Miracle-Gro IP royalty and branding license		212			-
Total non-cash items		519			290
EBITDA	$	(121	)	$	(556	)

The U.S GAAP measure most directly comparable to EBITDA is net earnings. The non-U.S. GAAP financial measure of EBITDA should not be considered as an alternative to net income (loss). EBITDA is not a presentation made in accordance with U.S. GAAP and has important limitations as an analytical tool. EBITDA should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Because EBITDA excludes some, but not all, items that affect net earnings and is defined differently by different companies, our definition of EBITDA may not be comparable to similarly titled measures of other companies.

25

Net Loss

The net loss for the nine months ended December 31, 2013 was $246,000, as compared to $7.9 million net loss in the prior–year as discussed above.

Liquidity and Capital Resources

After adjusting the net loss for non-cash items and changes in operating assets and liabilities, the net cash used by operating activities totaled $1.5 million for the nine months ended December 31, 2013, as compared to cash used of $466,000 in the prior year period.  

Non-cash items, comprising depreciation, amortization, loss on disposal of fixed assets, bad debt expense, and the gain on the forgiveness of debt, totaled to a net gain of $157,000 for the nine months ended December 31, 2013, as compared to a net gain of $7.1 million in the prior year period.  The increase principally reflected non-cash charges arising from the conversion of convertible debt into common equity in April 2012.

Changes in current assets used net cash of $1.9 million during the nine months ended December 31, 2013, principally from increases in inventory as we purchased cobranded inventory, and accounts receivable balances, as a result of our reintroduction into the retail channel during the peak holiday season.

As of December 31, 2013, the total inventory balance was $1.6 million, representing approximately 115 days of sales activity, and 51 days of sales activity, at the average daily rate of product cost expensed during the twelve months and three months ended December 31, 2013, respectively.  The days in inventory calculation is based on the three months of sales activity can be greatly impacted by the seasonality of our sales, which are at their highest level during our quarter ending December 31.

Current operating liabilities increased $793,000 during the nine months ended December 31, 2013, because of seasonal increases in all operating liability accounts.  Accounts payable as of December 31, 2013 totaled $756,000, representing approximately 29 days of daily expense activity, and 15 days of daily expense activity, at the average daily rate of expenses incurred during the twelve months and three months ended December 31, 2013, respectively.

Net investment activity provided $343,000 of cash in the current year period, principally because of the sale of our patent portfolio to Scotts Miracle-Gro.

Net financing activity provided net cash of $1.9 million during the nine months ended December 31, 2013, principally due the sale of convertible preferred stock, partially offset by debt repayments.

As of December 31, 2013, we had a cash balance of $1.3 million, of which $15,000 was restricted as collateral for various corporate obligations.  This compares to a cash balance of $567,000 as of March 31, 2013, of which $42,000 was restricted.

As of December 31, 2013 and March 31, 2013, the outstanding balance of our note payable and debt, including accrued interest, was as follows:

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Main Power Promissory Note	$	-	$	1,704
First Western Trust Term Loan		99		323
Sale of intellectual property liability (see Note 4)		271		-
Derivative warrant liability (see Note 4)		595		-
Notes Payable –Credit Card Receipts-Backed Notes		-		640
Pawnee Promissory Note		13		42
Total Debt		978		2,709
Less Notes Payable and Current Portion – Long Term Debt		978		1,540
Long Term Debt	$	-	$	1,169

Cash Requirements

We generally require cash to:

·   fund our operations and working capital requirements,

·   develop and execute our product development and market introduction plans,

26

·   execute our sales and marketing plans,

·   fund research and development efforts, and

·   pay debt obligations as they come due.

At this time, we do not expect to enter into additional capital leases to finance major purchases.  In addition, we do not currently have any binding commitments with third parties to obtain any material amount of equity or debt financing other than the financing arrangements described in this report.

Assessment of Future Liquidity and Results of Operations

Liquidity

To assess our ability to fund ongoing operating requirements, we developed assumptions regarding operating cash flow.  Critical sources of funding, and key assumptions and areas of uncertainty include:

·   our cash of $1.3 million ($15,000 of which is restricted as collateral for our various corporate obligations) as of December 31, 2013,

·   our cash of $1.5 million, ($15,000 of which is restricted as collateral for our various corporate obligations) as of February 4, 2014,

·   continued support of, and extensions of credit by, our suppliers and lenders,

·   our historical pattern of increased sales between September and March, and lower sales volume from April through August,

·   the level of spending necessary to support our planned initiatives, and

·   our sales to consumers, retailers, and international distributors, and the resulting cash flow from operations, which will depend in great measure on the success of  our direct-to-consumer sales initiatives, and the acceptance of the product at our various retail distribution customers

In the first quarter of Fiscal 2014, we entered into a Securities Purchase Agreement with a wholly owned subsidiary of Scotts Miracle-Gro.  Pursuant to the Securities Purchase Agreement, Scotts Miracle-Gro acquired the following securities for an aggregate purchase price of $4.0 million; (i) 2.6 million shares of our Series B Convertible Preferred Stock, par value $0.001 per share, and (ii) a warrant to purchase shares of our common stock.  After deducting offering expenses, including commissions and expenses paid to the Company’s advisor, net cash proceeds to the Company totaled to $3.8 million.  In addition, we also agreed to sell all intellectual property associated with our Hydroponic IP, other than the AeroGrow and AeroGarden trademarks, to Scotts Miracle-Gro for $500,000.  Finally, we repaid the outstanding balance on the MainPower Promissory Note, which outstanding, including all accrued interest, which totaled to $1.7 million as of March 31, 2013, was paid in full for $950,000.

Based on these facts and assumptions, we believe our existing cash and cash equivalents, along with the cash generated by our anticipated results from operations, will be sufficient to meet our operating needs for the next twelve months.   However, we may need to seek additional capital to provide a cash reserve against contingencies, address the seasonal nature of our working capital needs, and to enable us to invest further in trying to increase the scale of our business.  There can be no assurance we will be able to raise this additional capital.

Results of Operations

There are several factors that could affect our future results of operations.  These factors include, but are not limited to, the following:

· the effectiveness of our consumer marketing efforts in generating both direct-to-consumer sales, and sales to consumers by our retailer customer,

·      uncertainty regarding the impact of macroeconomic conditions on consumer spending,

· uncertainty regarding the capital markets and our access to sufficient capital to support our current and projected scale of operations,

· the seasonality of our business, in which we have historically experienced higher sales volume (October through January),

·      a continued, uninterrupted supply of product from our third-party manufacturing suppliers in China, and

·      the success of the Scotts Miracle-Gro relationship.

Off-Balance Sheet Arrangements

Other than our headquarter facility lease commitment incurred in the normal course of business, we do not have any off-balance sheet financing arrangements or liabilities, guarantee contracts, retained or contingent interest in transferred assets, and have not entered into any contracts for financial derivative such as futures, swaps, and options.

27

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

Our interest income is most sensitive to fluctuations in the general level of U.S. interest rates. As such, changes in U.S. interest rates affect the interest earned on our cash, cash equivalents, and short-term investments, and the value of those investments. Due to the short-term nature of our cash equivalents and investments, we have concluded that a change in interest rates does not pose a material market risk to us with respect to our interest income. Our debt carries fixed interest rates and therefore changes in the general level of market interest rates will not impact our interest expense during the terms of our existing debt arrangements.

Foreign Currency Exchange Risk

We transact business primarily in U.S. currency.  Although we purchase our products in U.S. dollars, the prices charged by our suppliers in Asia are predicated upon their cost for components, labor and overhead. Therefore, changes in the valuation of the U.S. dollar in relation to the Chinese currencies may cause our manufacturers to raise prices of our products which could reduce our profit margins.

In future periods, it is possible that we could be exposed to fluctuations in foreign currency exchange rates on accounts receivable from sales and net monetary assets denominated in foreign currencies and liabilities.  To date, however, virtually all of our transactions have been denominated in U.S. dollars.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports filed or submitted by the Company under the Securities Exchange Act of 1934 (the “Exchange Act”), is recorded, processed, summarized, and reported, within the time periods specified in the rules and forms of the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports filed under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure.

The Company carried out an evaluation, under the supervision and with the participation of its management, including its principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based upon and as of the date of that evaluation, the Company’s principal executive officer and financial officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports the Company files and submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

(b) Changes in Internal Controls

There were no changes in the Company’s internal controls or in other factors that could have significantly affected those controls during the three months ended December 31, 2013.

28

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, results of operations, financial condition, future results, and the trading price of our common stock. In addition to the other information set forth in this Quarterly Report, you should also carefully consider the factors described in “Part I. Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended March 31, 2013, which could materially affect our business, results of operations, financial condition, future results, and the trading price of our common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

29

Item 6. Exhibits

Exhibit Number	Description
3.1	Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K/A-2, filed November 16, 2006)
3.2	Certificate of Amendment to Articles of Incorporation, dated June 25, 2002 (incorporated by reference to Exhibit 3.2 of our Current Report on Form 8-K/A-2, filed November 16, 2006)
3.3	Certificate of Amendment to Articles of Incorporation, dated November 3, 2002 (incorporated by reference to Exhibit 3.3 of our Current Report on Form 8-K/A-2, filed November 16, 2006)
3.4	Certificate of Change to Articles of Incorporation, dated January 31, 2005 (incorporated by reference to Exhibit 3.4 of our Current Report on Form 8-K/A-2, filed November 16, 2006)
3.5	Certificate of Amendment to Articles of Incorporation, dated July 27, 2005 (incorporated by reference to Exhibit 3.5 of our Current Report on Form 8-K/A-2, filed November 16, 2006)
3.6	Certificate of Amendment to Articles of Incorporation, dated February 24, 2006 (incorporated by reference to Exhibit 3.5 of our Current Report on Form 8-K/A-2, filed November 16, 2006)
3.7	Certificate of Amendment to Articles of Incorporation, certified May 3, 2010 (incorporated by reference to Exhibit 3.7 of our Quarterly Report on Form 10-Q, filed August 12, 2010
3.8	Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, filed September 26, 2008)
3.9	Amendment to Bylaws (incorporated by reference to Exhibit 3.9 of our Annual Report on Form 10-K for the fiscal year ended March 31, 2009, filed July 6, 2009)
3.10	Certificate of Designations of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 3.7 of our Annual Report on Form 10-K for the fiscal year ended March 31, 2009, filed July 6, 2009)
3.11	Certificate of Amendment to Series A Convertible Preferred Stock Certificate of Designations, certified June 21, 2010 (incorporated by reference to Exhibit 3.11 of our Quarterly Report on Form 10-Q for the quarter year ended June 30, 2010, filed August 12, 2010)
3.12	Amendment Number 2 to Series A Convertible Preferred Stock Certificate of Designations, as filed with the Nevada Secretary of State on April 6, 2012 (incorporated by reference to our Current Report on Form 8-K, filed April 16, 2012)
31.1*	Certifications of the Chief Executive Officer Under Section 302 of the Sarbanes-Oxley Act.
31.2*	Certifications of the Chief Financial Officer Under Section 302 of the Sarbanes-Oxley Act.
32.1*	Certifications of the Chief Executive Officer Under Section 906 of the Sarbanes-Oxley Act.
32.2*	Certifications of the Chief Financial Officer Under Section 906 of the Sarbanes-Oxley Act.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
*  Filed herewith.

30

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	AeroGrow International, Inc.
Date:  February 11, 2014		/s/J. Michael Wolfe
		By: J. Michael Wolfe
		Its: President and Chief Executive Officer  (Principal Executive Officer) and Director
Date:  February 11, 2014		/s/Grey H. Gibbs
		By: Grey H. Gibbs
		Its: Vice President Accounting (Principal Finance Officer)

31

EX-31.1

EXHIBIT 31. 1

CERTIFICATIONS OF THE CHIEF EXECUTIVE OFFICER

UNDER SECTION 302 OF THE SARBANES-OXLEY ACT

I, J. Michael Wolfe certify that:

1.             I have reviewed this report on Form 10-Q for the period ended December 31, 2013 of AeroGrow International, Inc.;

2.             Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.             Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.             The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.             The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  February 11, 2014	By:	/s/ J. Michael Wolfe
		J. Michael Wolfe
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS OF THE CHIEF FINANCIAL OFFICER

UNDER SECTION 302 OF THE SARBANES-OXLEY ACT

I, Grey H. Gibbs, certify that:

1.            I have reviewed this report on Form 10-Q for the period ended December 31, 2013 of AeroGrow International, Inc.;

2.             Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.             Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.             The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.             The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  February 11, 2014	By:	/s/Grey H. Gibbs
		Grey H. Gibbs
		Vice President Accounting (Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATIONS OF THE CHIEF EXECUTIVE OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the Quarterly Report of AeroGrow International, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2013 (the “Report”), as filed with the Securities and Exchange Commission, I, J. Michael Wolfe, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by this Report.

Date:  February 11, 2014	By:	/s/ J. Michael Wolfe
		J. Michael Wolfe
		President and Chief Executive Officer (Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATIONS OF THE CHIEF FINANCIAL OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY ACT

            In connection with the Quarterly Report of AeroGrow International, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2013 (the “Report”), as filed with the Securities and Exchange Commission, I, Grey H. Gibbs, Vice President Accounting of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by this Report.

Date:  February 11, 2014	By:	/s/Grey H. Gibbs
		Grey H. Gibbs
		Vice President Accounting (Principal Financial Officer)

XML

8. Stockholders' Equity (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights (USD $) Share data in Thousands, except Per Share data, unless otherwise specified		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2013 Warrants Outstanding [Member]	Dec. 31, 2013 Weighted Average Exercise Price [Member]	Dec. 31, 2013 Aggregate Intrinsic Value [Member]	Mar. 31, 2013 Aggregate Intrinsic Value [Member]
Class of Warrant or Right [Line Items]
Outstanding, April 1, 2013	703	528
Outstanding, April 1, 2013 (in Dollars per share)	$ 17.22		$ 22.41
Outstanding, April 1, 2013 (in Dollars)				$ 0	$ 0
Granted		175
Granted (in Dollars per share)			$ 1.70
Exercised		0
Exercised (in Dollars per share)			$ 0
Expired		0
Expired (in Dollars per share)			$ 0.98
Outstanding, December 31, 2013	703	703
Outstanding, December 31, 2013 (in Dollars per share)	$ 17.22		$ 17.22
Outstanding, December 31, 2013 (in Dollars)				$ 0	$ 0

XML

2. Liquidity and Basis of Presentation (Details) - Schedule of Inventory, Current (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
Schedule of Inventory, Current [Abstract]
Finished goods	$ 1,124	$ 606
Raw materials	474	623
	$ 1,598	$ 1,229

XML

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions

9 Months Ended

Dec. 31, 2013

Disclosure Text Block Supplement [Abstract]

Preferred Stock [Text Block]

4.    Scotts Miracle-Gro Transactions – Convertible Preferred Stock, Warrants and Other Transactions

Series B Convertible Preferred Stock and Related Transactions

On April 22, 2013, the Company entered into a Securities Purchase Agreement with Scotts Miracle-Gro.  Pursuant to the Securities Purchase Agreement, Scotts Miracle-Gro acquired 2.6 million shares of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), and (ii) a warrant to purchase shares of the Company’s common stock (the “Warrant,” as described in greater detail below) for an aggregate purchase price of $4.0 million.  After deducting offering expenses, including commissions and expenses paid to the Company’s advisor, net cash proceeds totaled to $3.8 million.  The Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Promissory Note due to Main Power.  

The Company also issued a warrant to purchase 125,000 shares of the Company’s common stock to the placement agent.  This warrant has an exercise price of $1.54 per share (125% of the average closing price of the Company’s common stock during the five-day period prior to the April 22, 2013 closing date). The value of this warrant was estimated at $108,000, based on the Black-Scholes model with a stock price of $1.30, calculated exercise price of $1.54, expected life of three years, annualized volatility of 117.2% and a discount rate of 0.39%. The value of the warrant was recorded as stock issuance costs.

The Series B Preferred Stock is convertible into 2.6 million shares of the Company’s common stock ($4.0 million divided by a conversion price of $1.51 per share).  The Series B Preferred Stock bears a cumulative annual dividend of 8.0%, payable in shares of the Company’s common stock at a conversion price of $1.51 per share (subject to customary anti-dilution rights, as described in the Series B Preferred Stock Certificates of Designations).  The Series B Preferred Stock does not have a liquidation preference and shall vote on an “as-converted” basis with the common stock.  The stock dividend will accrue from day to day and will be payable in shares of our common stock within thirty days after the end of each fiscal year end.  The stock dividend issuable will be recorded at the fair market value of our common stock at the end of each quarter in the equity section of the balance sheet.  The corresponding charge will be recorded below net income to arrive at net income available to common shareholders.  The Series B Preferred Stock automatically converts into the Company’s common stock: (i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and the Company’s then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant.

The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a “fully diluted basis” (as defined in the Securities Purchase Agreement), constitute 80% of the Company’s outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.  The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).  In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.  The exercise price of the Warrant shall be equal to the quotient obtained by dividing:

(a)   an amount equal to (i) 1.34 times the trailing twelve months “Net Sales” (which includes sales of the Company’s products by Scotts Miracle-Gro and its affiliates) minus (ii) “Debt Outstanding” net of cash (as such terms are defined in the Warrant),

by

(b)   the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.

The Warrant expires on April 22, 2021, the eighth anniversary of the closing date.  The Warrant contains customary anti-dilution rights (for stock splits, stock dividends and sales of substantially all the Company’s assets).  Scotts Miracle-Gro also has the right to participate pro rata, based on Scotts Miracle-Gro’s percentage equity ownership in the Company (assuming the exercise of Scotts Miracle-Gro’s Warrant, but not the exercise of any options outstanding under the Company’s equity compensation plans) in future issuances of the Company’s equity securities.  Upon exercise of the Warrant and demand by Scotts Miracle-Gro, the Company must use its best efforts to file a Registration Statement on Form S-3, or, if the Company is not eligible for Form S-3, on Form S-1 (collectively, the “Registration Statement”), covering the shares of the Company’s common stock covered by the Preferred Stock and the Warrant, within 120 calendar days after receipt of Scotts Miracle-Gro’s demand for registration and shall use its best efforts to cause the Registration Statement to become effective as soon as possible thereafter.

The private offering and sale of the Series B Preferred Stock and Warrant was conducted in reliance upon exemptions from registration requirements under the Securities Act, including, without limitation, those under Regulation D promulgated under the Securities Act.  Scotts Miracle-Gro is an “accredited investor,” as defined in Rule 501 of Regulation D under the Securities Act.  Because the Series B Preferred Stock and the Warrant have not been registered under the Securities Act, they may not be reoffered or resold in the United States absent registration or an applicable exemption from registration.

The foregoing description of the Securities Purchase Agreement, the Certificates of Designations for the Series B Preferred Stock, the Warrant, and the resulting transaction is only a summary, does not purport to be complete, and is qualified in its entirety by reference to the full text of the applicable documents, each of which was included as an exhibit to the Company’s Current Report on Form 8-K, as filed with the SEC on April 23, 2013. The Warrant on the Series B Convertible Preferred Stock was accounted for as a liability at its estimated fair value of $595,000 as of December 31, 2013. The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period it is exercised or expires. The Company calculated the fair value of the Warrant during the quarter ended December 31, 2013 using a multiple based valuation model.

In conjunction with the private offering of Series B Preferred Stock and the Warrant above, the Company used $950,000 of the net proceeds to repay “in full” (with concessions) the Main Power Promissory Note.  Main Power also released the Company’s pledged collateral and the parties agreed to terminate the Letter Agreement and Promissory Note effective as of April 22, 2013, as further described in Note 3.  The Company did not incur any early termination penalties. As of April 23, 2013, there was $237,000 in consignment inventory held by Main Power that was fully reserved for during the three-month period ended June 30, 2013.

In conjunction with the private offering described above, the Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues.

For more details, please refer to Note 8 “Subsequent Events” to the financial statements included in the Company’s Annual Report on Form 10-K, as filed with the SEC on July 1, 2013.

XML

5. Equity Compensation Plans (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Dec. 31, 2013 Equity Compensation Plan (2005 Plan) [Member]	Dec. 31, 2012 Equity Compensation Plan (2005 Plan) [Member]	Dec. 31, 2013 Equity Compensation Plan (2005 Plan) [Member]	Dec. 31, 2012 Equity Compensation Plan (2005 Plan) [Member]
5. Equity Compensation Plans (Details) [Line Items]
Stockholders' Equity, Reverse Stock Split	1-for-100
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		180		331
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period		75	1	109	1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		2	0	2	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares		274		274
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)		$ 316		$ 316

XML

4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.001		$ 0.001
Fair Value Adjustment of Warrants (in Dollars)	$ 108,000	$ 0
Fair Value Inputs, Discount Rate	15.00%
Warrants, Description of Warrants	issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock.
Scotts Miracle-Gro Company [Member] | Series B Preferred Stock [Member]
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	2,600,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.001
Stock Issued During Period, Value, New Issues (in Dollars)	4,000,000
Proceeds from Issuance of Convertible Preferred Stock (in Dollars)	3,800,000
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	2,600,000
Preferred Stock, Conversion Basis	$4.0 million divided by a conversion price of $1.51 per share
Preferred Stock, Dividend Rate, Percentage	8.00%
Preferred Stock, Dividend Payment Terms	The stock dividend will accrue from day to day and will be payable in shares of our common stock within thirty days after the end of each fiscal year end
Convertible Preferred Stock, Terms of Conversion	(i) upon the affirmative election of the holders of at least a majority of the then outstanding shares of the Series B Preferred Stock voting together as a single class on an as-if-converted to common stock basis; or (ii) if, at the date of exercise in whole or in part of the Warrant, the holder (or holders) of the Series B Preferred Stock own 50.1% of the issued and the Company's then-outstanding common stock, giving effect to the issuance of shares of common stock in connection with the conversion of the Series B Preferred Stock and such exercise of the Warrant
Warrants, Description of Warrants	The Warrant entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a "fully diluted basis" (as defined in the Securities Purchase Agreement), constitute 80% of the Company's outstanding capital stock (when added to all other shares owned by Scotts Miracle-Gro), as calculated as of the date or dates of exercise.The Warrant can be exercised at any time and from time to time for a period of five years between April 22, 2016 and April 22, 2021 (the third and eighth anniversary of the closing date).In addition, the Warrant can be exercised in any increment; there is no obligation to exercise the entire Warrant at one time.The exercise price of the Warrant shall be equal to the quotient obtained by dividing:(a) an amount equal to (i) 1.34 times the trailing twelve months "Net Sales" (which includes sales of the Company's products by Scotts Miracle-Gro and its affiliates) minus (ii) "Debt Outstanding" net of cash (as such terms are defined in the Warrant),by(b) the total shares of capital stock outstanding, including outstanding in-the-money options and warrants, but not the Warrant contemplated in this Private Offering.
Derivative Liability (in Dollars)	595,000
Scotts Miracle-Gro Company [Member] | Placement Agent for Securities Purchase Agreement [Member]
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)	125,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	1.54
Class of Warrant or Rights, Exercise Price, Description	125% of the average closing price of the Company's common stock during the five-day period prior to the April 22, 2013 closing date
Fair Value Adjustment of Warrants (in Dollars)	108,000
Share Price (in Dollars per share)	$ 1.30
Fair Value Assumptions, Expected Term	3 years
Fair Value Assumptions, Expected Volatility Rate	117.20%
Fair Value Inputs, Discount Rate	0.39%
Main Power Promissory Note [Member]
4. Scotts Miracle-Gro Transactions - Convertible Preferred Stock, Warrants and Other Transactions (Details) [Line Items]
Repayments of Debt (in Dollars)	$ 950,000

XML

5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable (USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Dec. 31, 2013
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
OPTIONS OUTSTANDING - Options (in Shares)	499
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	4 years 109 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 1.77
OPTIONS OUTSTANDING - Aggregate Intrinsic Value (in Dollars)	$ 497
OPTIONS EXERCISABLE - Options (in Shares)	225
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	4 years 25 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 1.88
OPTIONS EXERCISABLE - Aggregate Intrinsic Value (in Dollars)	$ 271
Options Exercise Price $1.01 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 1.01
OPTIONS OUTSTANDING - Options (in Shares)	162
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	4 years 36 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 1.01
OPTIONS EXERCISABLE - Options (in Shares)	74
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	4 years 36 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 1.01
Option Exercise Price $1.10 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 1.10
OPTIONS OUTSTANDING - Options (in Shares)	100
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	4 years 3 months
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 1.10
OPTIONS EXERCISABLE - Options (in Shares)	75
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	4 years 3 months
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 1.10
Option Exercise Price $1.21 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 1.21
OPTIONS OUTSTANDING - Options (in Shares)	50
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	4 years 3 months
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 1.21
OPTIONS EXERCISABLE - Options (in Shares)	38
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	4 years 3 months
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 1.21
Options Exercise Price $2.20 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 2.20
OPTIONS OUTSTANDING - Options (in Shares)	164
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	4 years 281 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 2.20
OPTIONS EXERCISABLE - Options (in Shares)	23
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	4 years 281 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 1.21
Options Exercise Price $2.42 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 2.42
OPTIONS OUTSTANDING - Options (in Shares)	10
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	4 years 281 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 2.42
OPTIONS EXERCISABLE - Options (in Shares)	2
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	4 years 281 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 1.21
Options Exercise Price $7.00 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 7.00
OPTIONS OUTSTANDING - Options (in Shares)	1
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	1 year 120 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 7.00
OPTIONS EXERCISABLE - Options (in Shares)	1
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	1 year 120 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 7.00
Options Exercise Price $8.00 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 8.00
OPTIONS OUTSTANDING - Options (in Shares)	5
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	1 year 335 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 8.00
OPTIONS EXERCISABLE - Options (in Shares)	5
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	1 year 335 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 8.00
Options Exercise Price $12.00 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 12.00
OPTIONS OUTSTANDING - Options (in Shares)	1
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	219 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 12.00
OPTIONS EXERCISABLE - Options (in Shares)	1
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	219 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 12.00
Options Exercise Price $13.00 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 13.00
OPTIONS OUTSTANDING - Options (in Shares)	1
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	222 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 13.00
OPTIONS EXERCISABLE - Options (in Shares)	1
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	222 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 13.00
Options Exercise Price $14.00 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 14.00
OPTIONS OUTSTANDING - Options (in Shares)	0
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	1 year 171 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 14.00
OPTIONS EXERCISABLE - Options (in Shares)	0
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	1 year 171 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 14.00
Options Exercise Price $18.00 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 18.00
OPTIONS OUTSTANDING - Options (in Shares)	5
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	62 days
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 18.00
OPTIONS EXERCISABLE - Options (in Shares)	5
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	62 days
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 18.00
Options Exercise Price $20.00 [Member]
5. Equity Compensation Plans (Details) - Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Line Items]
Exercise Price Range	$ 20.00
OPTIONS OUTSTANDING - Options (in Shares)	0
OPTIONS OUTSTANDING - Weighted-Average Remaining Contractual Life (Years)	1 year
OPTIONS OUTSTANDING - Weighted-Average Exercise Price	$ 20.00
OPTIONS EXERCISABLE - Options (in Shares)	0
OPTIONS EXERCISABLE - Weighted-Average Remaining Contractual Life (Years)	1 year
OPTIONS EXERCISABLE - Weighted-Average Exercise Price	$ 20.00

XML

6. Income Taxes (Details)	Dec. 31, 2013	Mar. 31, 2013
Income Tax Disclosure [Abstract]
Valuation allowance, percentage	100.00%	100.00%

XML

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt

9 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

3.    Notes Payable, Long Term Debt and Current Portion – Long Term Debt

Refer to the Company’s Annual Report on Form 10-K for the year ended March 31, 2013, as filed with the SEC on July 1, 2013 for a detailed discussion on Notes Payable, Long Term Debt and Current Portion – Long Term Debt.  The following are the changes to our Notes Payable, Long Term Debt and Current Portion – Long Term Debt for the periods presented.

As of December 31, 2013 and March 31, 2013, the outstanding balance of the Company’s note payable and debt, including accrued interest, is as follows:

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Main Power promissory note	$	-	$	1,704
First Western Trust term loan		99		323
Notes Payable –credit card receipts-backed notes		-		640
Pawnee promissory note		13		42
Sale of intellectual property liability (see Note 4)		271		-
Derivative warrant liability (see Note 4)		595		-
Total debt		978		2,709
Less notes payable and current portion – long term debt		978		1,540
Long term debt	$	-	$	1,169

Main Power Promissory Note

On June 30, 2009, the Company entered into a Letter Agreement (“Letter Agreement”) with Main Power Electrical Factory, Ltd. (“Main Power”) and executed a Promissory Note.  Pursuant to the terms of the Letter Agreement, Main Power agreed to release the Company from $1.4 million of existing obligations owed by the Company to Main Power in return for the execution of the Promissory Note for the same amount which was amended several times since inception to extend the payment schedule, maturity date and amount owed.   On April 23, 2013, the MainPower Promissory Note outstanding, including all accrued interest, was paid in full for $950,000.

As of April 23, 2013, the Company had consigned approximately $237,000 of inventory with Main Power, all of which was fully reserved for during the three month period ended June 30, 2013. The inventory reserve combined with the payment in full resulted in a net gain of $489,000, which was recognized as other income and expense for the nine months ended December 31, 2013.

First Western Trust Term Loan

On May 21, 2010, the Company, First Western Trust Bank (“FWTB”) and Jack J. Walker, our Chairman, as guarantor, executed a business loan agreement and related promissory note (the “FWTB Term Loan”) for a four-year loan in an initial principal amount of $1.0 million.  The FWTB Term Loan is secured by a lien on our assets and bears interest at a fixed rate of 7.25% per annum.  The Company makes equal monthly payments of principal/interest over the four-year term of the FWTB Term Loan, which has a final maturity date of May 21, 2014.  The terms and conditions of the FWTB Term Loan include limitations on the Company incurring additional debt and paying dividends on our stock without the consent of FWTB.  In the event of a default under the FWTB Term Loan, FWTB has the option to declare the loan immediately due and payable.  

As of December 31, 2013, $99,000 was outstanding under the FWTB Term Loan, including accrued interest, and we were current and in compliance with all terms and conditions.

Notes Payable – 2012 Credit Card Receipts-Backed Notes

On September 14, 2012, the Company closed on the private sale of $1.3 million in Series 2012CC 15% secured promissory notes backed by a portion of the Company’s prospective credit card receipts, (the “2012 Credit Card Notes”) and 128,573 shares of common stock (collectively, the “2012 Credit Card Offering”).  Consideration for the 2012 Credit Card Offering comprised $1.3 million in cash.  After deducting $46,000 of placement agent sales commissions (5% on third-party investors, 3% on Company-referred investors and 0% on investments by officers and directors of the Company) and expenses, net cash proceeds to the Company totaled $1.2 million.   In addition, the Company issued 12,858 shares of common stock to the placement agent as additional sales compensation, representing one share of common stock for every 10 shares issued to investors in the 2012 Credit Card Offering.

The Company used the proceeds from the 2012 Credit Card Offering to invest in advertising and marketing programs to support its direct-to-consumer business, purchase inventory, provide other general working capital, repay $198,000 of the 2011 Credit Card Notes (including accrued interest) and pay commissions and expenses related to the private offering.  

As of December 17, 2013, the remaining balance and accrued interest on the 2012 Credit Card Notes were repaid in full. 

Pawnee Lease Promissory Note

On November 30, 2011, the Company executed a promissory note (the “Lease Promissory Note”) in the principal amount of $116,000 in favor of Pawnee Properties, LLC (“Pawnee”).  The Lease Promissory Note details the terms and conditions pursuant to which the Company will pay to Pawnee past due rent and building operating expenses related to our headquarters lease.  The Lease Promissory Note carries an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter.  

As of December 31, 2013, the outstanding balance of the Lease Promissory Note, including accrued interest, was $13,000 and we were current and in compliance with all terms and conditions.

Debt Associated with Scotts Miracle-Gro Transaction

On April 22, 2013, the Company issued Series B Convertible Preferred Stock to a wholly-owned subsidiary of Scotts Miracle-Gro.  Pursuant to U.S. GAAP, the Company has classified the warrant as a liability at its estimated fair value.  The derivative warrant liability will be re-measured to fair value, on a recurring basis, at the end of each reporting period until it is exercised or expires.  The valuation techniques used to determine the fair value of the derivative warrant liability and the terms of the warrant are further explained in Note 4.  As of December 31, 2013 the fair value of the warrant was $595,000.

The Company and Scotts Miracle-Gro also agreed to enter an Intellectual Property Sale Agreement, a Technology License Agreement, a Brand License Agreement, and a Supply Chain Services Agreement.  The Intellectual Property Sale Agreement and the Technology License constitute an agreement of sales of future revenues. Since the Company received cash from Scotts Miracle-Gro and agreed to pay for a defined period a specified percentage of revenue, and because the Company has significant involvement in the generation of its revenue, the excess paid over net book value is classified as debt and is being amortized under the effective interest method.  As of December 31, 2013, $271,000 was recorded as debt on the condensed balance sheets.

XML

8. Stockholders' Equity (Details)	9 Months Ended	12 Months Ended
	Dec. 31, 2013	Mar. 31, 2013
Stockholders' Equity Note [Abstract]
Stockholders' Equity, Reverse Stock Split		1-for-100
Warrants, Description of Warrants	issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock.

XML

CONDENSED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
Current assets
Cash	$ 1,274	$ 525
Restricted cash	15	42
Accounts receivable, net of allowance for doubtful accounts of $13 and $1 at December 31, 2013 and March 31, 2013, respectively	1,473	173
Other receivables	131	169
Inventory	1,598	1,229
Prepaid expenses and other	223	205
Total current assets	4,714	2,343
Property and equipment, net of accumulated depreciation of $2,982 and $2,869 at December 31, 2013 and March 31, 2013, respectively	335	266
Other assets
Intangible assets, net of $0 and $135 of accumulated amortization at December 31, 2013 and March 31, 2013, respectively	2	195
Deposits	146	145
Deferred debt issuance costs, net of accumulated amortization of $271 and $255 at December 31, 2013 and March 31, 2013, respectively	7	23
Total other assets	155	363
Total assets	5,204	2,972
Current liabilities
Accounts payable	756	379
Accrued expenses	809	292
Customer deposits	0	157
Deferred rent	4	6
Notes payable	0	518
Notes payable – related party	0	122
Current portion – long term debt	112	900
Derivative warrant liability	595
Debt associated with sale of IP	271	0
Total current liabilities	2,547	2,374
Long term debt	0	1,169
Total liabilities	2,547	3,543
Commitments and contingencies
Stockholders' equity (deficit)
Preferred stock, $.001 par value, 20,000,000 shares authorized, 2,649,007 and no shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively	3	0
Common stock, $.001 par value, 750,000,000 shares authorized, 5,906,635 and 5,904,877 shares issued and outstanding at December 31, 2013 and March 31, 2013, respectively	6	6
Additional paid-in capital	79,167	75,427
Stock dividend to be distributed	367	0
Accumulated deficit	(76,886)	(76,004)
Total stockholders' equity (deficit)	2,657	(571)
Total liabilities and stockholders' equity (deficit)	$ 5,204	$ 2,972

XML

1. Description of the Business

9 Months Ended

Dec. 31, 2013

Disclosure Text Block [Abstract]

Basis of Accounting [Text Block]

1.    Description of the Business

AeroGrow International, Inc. (the “Company," “we,” “AeroGrow,” or “our”) was formed as a Nevada corporation in March 2002. The Company’s principal business is developing, marketing, and distributing advanced indoor aeroponic garden systems designed and priced to appeal to the consumer gardening, cooking and small indoor appliance markets worldwide.   The Company manufactures, distributes and markets six different models of its AeroGarden systems in multiple colors, as well as over 40 varieties of seed pod kits and a full line of accessory products through multiple channels including retail distribution, catalogue and direct-to-consumer sales primarily in the United States and Canada, as well as selected countries in Europe, Asia and Australia.

XML

2. Liquidity and Basis of Presentation (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
Liabilities
Derivative warrant liability	$ 595
Long-term debt	978	2,709
Estimate of Fair Value Measurement [Member]
Liabilities
Notes payable	0	610
Sale of intellectual property liability	178	0
Derivative warrant liability	595	0
Long-term debt	109	1,726
Total	882	2,336
Reported Value Measurement [Member]
Liabilities
Notes payable	0	641
Sale of intellectual property liability	271	0
Derivative warrant liability	595	0
Long-term debt	112	2,068
Total	$ 978	$ 2,709

XML

2. Liquidity and Basis of Presentation (Details) - Schedule of Deferred Advertising Costs (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
Schedule of Deferred Advertising Costs [Abstract]
Deferred advertising and media	$ 6	$ 4

XML

2. Liquidity and Basis of Presentation

9 Months Ended

Dec. 31, 2013

Disclosure Text Block [Abstract]

Basis of Presentation and Significant Accounting Policies [Text Block]

2.    Liquidity and Basis of Presentation

Interim Financial Information

The unaudited interim financial statements of the Company included herein have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim reporting including the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. These condensed statements do not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for annual audited financial statements and should be read in conjunction with the Company’s audited financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2013, as filed with the SEC on July 1, 2013.

In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, including normal recurring adjustments, necessary to present fairly the financial position of the Company at December 31, 2013, the results of operations for the three- and nine–month periods ended December 31, 2013 and 2012, and the cash flows for the nine–month periods ended December 31, 2013 and 2012. The results of operations for the three and nine months ended December 31, 2013 are not necessarily indicative of the expected results of operations for the full year or any future period. In this regard, the Company’s business is highly seasonal, with approximately 49.3% of revenues in the fiscal year ended March 31, 2013 (“Fiscal 2013”) occurring in the four consecutive calendar months of October through January.  Furthermore, during the nine-month period ended December 31, 2013, the Company has curtailed sales and incurred additional product and marketing expenses while it cobranded inventory and advertising materials with the Scotts Miracle-Gro trade name.  The balance sheet as of March 31, 2013 is derived from the Company’s audited financial statements.

Sources of funding to meet prospective cash requirements include the Company’s existing cash balances, cash flow from operations, and borrowings under the Company’s debt arrangements.  We may need to seek additional capital, however, to provide a cash reserve against contingencies, address the seasonal nature of our working capital needs, and to enable us to invest further in trying to increase the scale of our business.  There can be no assurance we will be able to raise this additional capital.

Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term.

Net Income (Loss) per Share of Common Stock

The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted earnings per share (“EPS”).  Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS, but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. 

The following table presents the computation of basic and diluted net income per share for the three months ended December 31, 2013 (in thousands, except per share amounts):

	December 31, 2013
Net income available to common shareholders	$	76
Basic:
Weighted-average shares outstanding		5,906
Basic net income per share	$	0.01
Diluted:
Weighted-average shares outstanding		5,906
Add: Dilutive potential shares-Stock options		86
Weighted-average shares used in computing diluted net income per share		5,992
Diluted net income per share	$	0.01

Employee stock options to purchase approximately 13,000 shares were outstanding and approximately 528,000 warrants to purchase common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been antidilutive in the periods presented.

Reclassifications

Certain prior year amounts have been reclassified to conform to current year presentation.

Concentrations of Risk

ASC 825-10-50-20requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of December 31, 2013.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.

Customers:

For the three months ended December 31, 2013, two customers, Amazon.com and Costco, represented 39.2% and 10.7% of the Company’s net revenue, respectively. For the three months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 19.3% and 12.8% of the Company’s net revenue, respectively. For the nine months ended December 31, 2013, two customers, Amazon.com and Costco, represented 33.6% and 7.9% of the Company’s net revenue, respectively. For the nine months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 10.4% and 7.9% of the Company’s net revenue, respectively.

Suppliers:

For the three months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $839,000, $707,000, and $205,000, representing 29.3%, 24.7%, and 7.2% of cost of revenue, respectively. For the three months ended December 31, 2012, the Company purchased inventories and other inventory-related items from two suppliers totaling $263,000 and $254,000, representing 15.8% and 15.3% of cost of revenue, respectively. For the nine months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $1.4 million, $992,000, and $270,000 representing 34.4%, 24.9%, and 6.8%, of cost of revenue, respectively. For the nine months ended December 31, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $587,000, $433,000, $392,000, and $334,000 representing 20.2%, 14.9%, 13.5%, and 11.5% of cost of revenue, respectively.

The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on operations.

Accounts Receivable:

As of December 31, 2013, the Company had two customers, Amazon.com and Costco, that represented 62.3% and 23.6% of the Company’s outstanding accounts receivable, respectively.  As of March 31, 2013, the Company one customer, Amazon.com  who represented 61.2% of outstanding accounts receivable.  The Company believes that all receivables from these customers are collectible.

Fair Value of Financial Instruments

The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities. ASC 820 provides for a standard definition of fair value to be used in new and existing pronouncements. This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants.  ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.

Level 1 – Quoted prices in active markets for identical assets.

Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations.

Level 3 – Unobservable inputs that are supported by little or no market activity.

The carrying value of financial instruments including receivables and accounts payable, approximates their fair value at December 31, 2013 and March 31, 2013 due to the relatively short-term nature of these instruments. As of December 31, 2013 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.

In conjunction with a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with the subsidiary, “Scotts Miracle-Gro”) on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended December 31, 2013 using a multiple based valuation model.  As of December 31, 2013, the Company measured the warrant at fair value and will continue to do so on a quarterly basis.  As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.

	December 31, 2013 (in thousands)				March 31, 2013 (in thousands)
	Fair Value		Carry Value		Fair Value		Carry Value
Liabilities
Notes payable	$	-	$	-	$	610	$	641
Sale of intellectual property liability		178		271		-		-
Derivative warrant liability		595		595		-		-
Long-term debt		109		112		1,726		2,068
Total	$	882	$	978	$	2,336	$	2,709

Accounts Receivable and Allowance for Doubtful Accounts

The Company sells its products to retailers and consumers. Consumer transactions are primarily paid by credit card.  Retailer sales terms vary by customer, but generally range from net 30 days to net 60 days.  Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company's allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $13,000 and $1,000 at December 31, 2013 and March 31, 2013, respectively.

Other Receivables

In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of December 31, 2013 and March 31, 2013, the balance in this reserve account was $131,000 and $169,000, respectively.

Advertising and Production Costs

The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct-response catalogues, and related direct-response advertising costs, in accordance with ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct-to-consumer advertising costs incurred are reported as assets and are amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.  

As the Company has re-entered the retail distribution channel, the Company has expanded its advertising to online gateway and portal advertising, as well as placement in third party catalogues.

Advertising expense for the three and nine months ended December 31, 2013 and December 31, 2012, were as follows:

	Three Months Ended December 31, (in thousands)				Nine Months Ended December 31, (in thousands)
	2013		2012		2013		2012
Direct-to-consumer	$	391	$	534	$	506	$	825
Retail		390		1		393		1
Total advertising expense	$	781	$	535	$	899	$	826

As of December 31, 2013 and March 31, 2013, the Company deferred $6,000 and $4,000, respectively, related to such media and advertising costs.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Deferred advertising and media	$	6	$	4

Inventory

Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at cost.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Finished goods	$	1,124	$	606
Raw materials		474		623
	$	1,598	$	1,229

The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of December 31, 2013 and March 31, 2013, the Company had reserved $332,000 for inventory obsolescence.

Revenue Recognition

The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.

The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives.  Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive. As of December 31, 2013 and March 31, 2013, the Company had accrued $236,000 and $43,000, respectively, as its estimate for the foregoing deductions and allowances.

Warranty and Return Reserves

The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold, but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.  Based upon the foregoing, the Company has recorded a reserve for potential future warranty costs of $14,000 and $10,000 as of December 31, 2013 and March 31, 2013, respectively.

The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of December 31, 2013 and March 31, 2013, the Company has recorded a reserve for customer returns of $80,000 and $27,000, respectively.

Recently Issued Accounting Pronouncements

In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. This new guidance will not have a material impact on our financial statements.

XML

CONDENSED BALANCE SHEETS (Parentheticals) (USD $) In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
Allowance for doubtful accounts (in Dollars)	$ 13	$ 1
Accumulated depreciation (in Dollars)	2,982	2,869
Accumulated amortization of intangible assets (in Dollars)	0	135
Accumulated amortization of deferred debt issuance costs (in Dollars)	$ 271	$ 255
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in Shares)	20,000,000	20,000,000
Preferred stock, shares issued (in Shares)	2,649,007	0
Preferred stock, shares outstanding (in Shares)	2,649,007	0
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in Shares)	750,000,000	750,000,000
Common stock, shares issued (in Shares)	5,906,635	5,904,877
Common stock, shares outstanding (in Shares)	5,906,635	5,904,877

XML

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Tables)

9 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

Schedule of Debt [Table Text Block]

As of December 31, 2013 and March 31, 2013, the outstanding balance of the Company’s note payable and debt, including accrued interest, is as follows:

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Main Power promissory note	$	-	$	1,704
First Western Trust term loan		99		323
Notes Payable –credit card receipts-backed notes		-		640
Pawnee promissory note		13		42
Sale of intellectual property liability (see Note 4)		271		-
Derivative warrant liability (see Note 4)		595		-
Total debt		978		2,709
Less notes payable and current portion – long term debt		978		1,540
Long term debt	$	-	$	1,169

XML

Document And Entity Information	9 Months Ended
	Dec. 31, 2013	Feb. 07, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	AeroGrow International, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		5,906,634
Amendment Flag	false
Entity Central Index Key	0001316644
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2013
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

XML

5. Equity Compensation Plans (Tables)

9 Months Ended

Dec. 31, 2013

Share-based Arrangements with Employees and Nonemployees [Abstract]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]

Information regarding all stock options outstanding under the 2005 Plan as of December 31, 2013 is as follows:

		OPTIONS OUTSTANDING								OPTIONS EXERCISABLE
				Weighted-								Weighted-
				average		Weighted-		Aggregate				average		Weighted-		Aggregate
				Remaining		average		Intrinsic				Remaining		average		Intrinsic
Exercise		Options		Contractual		Exercise		Value		Options		Contractual		Exercise		Value
price		(in thousands)		Life (years)		Price		(in thousands)		(in thousands)		Life (years)		Price		(in thousands)
$	1.01		162		4.10	$	1.01				74		4.10	$	1.01
$	1.10		100		4.25	$	1.10				75		4.25	$	1.10
$	1.21		50		4.25	$	1.21				38		4.25	$	1.21
$	2.20		164		4.77	$	2.20				23		4.77	$	1.21
$	2.42		10		4.77	$	2.42				2		4.77	$	1.21
$	7.00		1		1.33	$	7.00				1		1.33	$	7.00
$	8.00		5		1.92	$	8.00				5		1.92	$	8.00
$	12.00		1		0.60	$	12.00				1		0.60	$	12.00
$	13.00		1		0.61	$	13.00				1		0.61	$	13.00
$	14.00		0		1.47	$	14.00				0		1.47	$	14.00
$	18.00		5		0.17	$	18.00				5		0.17	$	18.00
$	20.00		0		1.00	$	20.00				0		1.00	$	20.00
			499		4.30	$	1.77	$	497		225		4.07	$	1.88	$	271

XML

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Net revenue	$ 4,968	$ 2,972	$ 6,767	$ 5,533
Cost of revenue	2,867	1,665	3,977	2,905
Gross profit	2,101	1,307	2,790	2,628
Operating expenses
Research and development	17	94	72	302
Sales and marketing	1,262	882	2,127	1,765
General and administrative	451	390	1,231	1,407
Total operating expenses	1,730	1,366	3,430	3,474
Profit (loss) from operations	371	(59)	(640)	(846)
Other (income) expense, net
Fair value changes in derivative warrant liability	18	0	31	0
Interest expense	14	228	65	441
Interest expense – related party	2	9	8	25
Debt conversion cost	0	0	0	6,648
Other expense (income)	35	1	(498)	(97)
Total other expense, net	69	238	(394)	7,017
Net income (loss)	302	(297)	(246)	(7,863)
Less: Deemed dividend on convertible preferred stock	0	0	(268)	0
Less: Preferred stock dividend	(226)	0	(367)	0
Net income (loss) attributable to common shareholders	$ 76	$ (297)	$ (881)	$ (7,863)
Net income (loss) per share, basic (in Dollars per share)	$ 0.01	$ (0.05)	$ (0.10)	$ (1.35)
Net income (loss) per share, diluted (in Dollars per share)	$ 0.01	$ (0.05)	$ (0.10)	$ (1.35)
Weighted average number of common shares outstanding, basic (in Shares)	5,906	5,905	5,905	5,826
Weighted average number of common shares outstanding, diluted (in Shares)	5,992	5,905	5,905	5,826

XML

7. Related Party Transactions

9 Months Ended

Dec. 31, 2013

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

7.    Related Party Transactions

See Note 3. Notes Payable, Long Term Debt and Current Portion – Long Term Debt for disclosure of related party transactions.

XML

6. Income Taxes

9 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

6.    Income Taxes

The Company follows the guidance in ASC 740, Accounting for Uncertainty in Income Taxes (“ASC 740”) which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements.  This interpretation defines the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.

Deferred income taxes are recognized for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at the end of each period, based on enacted laws and statutory rates applicable to the periods in which the differences are expected to affect taxable income.  Any liability for actual taxes to taxing authorities is recorded as income tax liability. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.  A valuation allowance is established against such assets where management is unable to conclude more likely than not that such asset will be realized. As of December 31, 2013 and March 31, 2013, the Company recognized a valuation allowance equal to 100% of the net deferred tax asset balance and the Company has no unrecognized tax benefits related to uncertain tax positions.

XML

2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense [Line Items]
Advertising Expense	$ 781	$ 535	$ 899	$ 826
Direct-to-Customer Advertising [Member]
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense [Line Items]
Advertising Expense	391	534	506	825
Retail Advertising [Member]
2. Liquidity and Basis of Presentation (Details) - Schedule of Advertising Expense [Line Items]
Advertising Expense	$ 390	$ 1	$ 393	$ 1

XML

8. Stockholders' Equity (Tables)

9 Months Ended

Dec. 31, 2013

Stockholders' Equity Note [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of the Company’s common stock warrant activity for the period from April 1, 2013 through December 31, 2013 is presented below:

	Warrants Outstanding (in thousands)		Weighted Average Exercise Price		Aggregate Intrinsic Value
Outstanding, April 1, 2013		528	$	22.41	$	0.00
Granted		175		1.70
Exercised		-		-
Expired		0		0.98
Outstanding, December 31, 2013		703	$	17.22	$	0.00

Schedule of Stockholders Equity [Table Text Block]

As of December 31, 2013, the Company had the following outstanding warrants to purchase its common stock:

		Weighted Average
Warrants Outstanding (in thousands)		Exercise Price		Remaining Life (years)
	125	$	1.54		4.31
	50	$	2.10		4.77
	394	$	7.00		3.28
	122	$	20.00		1.37
	1	$	25.00		0.77
	3	$	100.00		0.13
	7	$	800.00		0.68
	1	$	825.00		0.68
	703	$	17.22		3.19

XML

Accounting Policies, by Policy (Policies)

9 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  It is reasonably possible that a change in the Company’s estimates will occur in the near term.

Earnings Per Share, Policy [Policy Text Block]

Net Income (Loss) per Share of Common Stock

The Company computes net income (loss) per share of common stock in accordance with Accounting Standards Codification (“ASC”) 260.  ASC 260 requires companies with complex capital structures to present basic and diluted earnings per share (“EPS”).  Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average shares of common stock outstanding for the period. Diluted EPS is similar to basic EPS, but presents the dilutive effect on a per share basis of potential common stock (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented. Potential shares of common stock that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. 

The following table presents the computation of basic and diluted net income per share for the three months ended December 31, 2013 (in thousands, except per share amounts):

	December 31, 2013
Net income available to common shareholders	$	76
Basic:
Weighted-average shares outstanding		5,906
Basic net income per share	$	0.01
Diluted:
Weighted-average shares outstanding		5,906
Add: Dilutive potential shares-Stock options		86
Weighted-average shares used in computing diluted net income per share		5,992
Diluted net income per share	$	0.01

Employee stock options to purchase approximately 13,000 shares were outstanding and approximately 528,000 warrants to purchase common stock were outstanding but were not included in the computation of diluted net income per share because the effect of including such shares would have been antidilutive in the periods presented.

Reclassification, Policy [Policy Text Block]

Reclassifications

Certain prior year amounts have been reclassified to conform to current year presentation.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentrations of Risk

ASC 825-10-50-20requires disclosure of significant concentrations of credit risk regardless of the degree of such risk.  Financial instruments with significant credit risk include cash deposits.  The amount on deposit with one financial institution exceeded the $250,000 federally insured limit as of December 31, 2013.  However, management believes that the financial institution is financially sound and the risk of loss is minimal.

Customers:

For the three months ended December 31, 2013, two customers, Amazon.com and Costco, represented 39.2% and 10.7% of the Company’s net revenue, respectively. For the three months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 19.3% and 12.8% of the Company’s net revenue, respectively. For the nine months ended December 31, 2013, two customers, Amazon.com and Costco, represented 33.6% and 7.9% of the Company’s net revenue, respectively. For the nine months ended December 31, 2012, two customers, Amazon.com and Canadian Tire Corporation, represented 10.4% and 7.9% of the Company’s net revenue, respectively.

Suppliers:

For the three months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $839,000, $707,000, and $205,000, representing 29.3%, 24.7%, and 7.2% of cost of revenue, respectively. For the three months ended December 31, 2012, the Company purchased inventories and other inventory-related items from two suppliers totaling $263,000 and $254,000, representing 15.8% and 15.3% of cost of revenue, respectively. For the nine months ended December 31, 2013, the Company purchased inventories and other inventory-related items from three suppliers totaling $1.4 million, $992,000, and $270,000 representing 34.4%, 24.9%, and 6.8%, of cost of revenue, respectively. For the nine months ended December 31, 2012, the Company purchased inventories and other inventory-related items from four suppliers totaling $587,000, $433,000, $392,000, and $334,000 representing 20.2%, 14.9%, 13.5%, and 11.5% of cost of revenue, respectively.

The Company’s primary contract manufacturers are located in China.  As a result, the Company may be subject to political, currency, regulatory and weather/natural disaster risks.  Although the Company believes alternate sources of manufacturing could be obtained, these risks could have an adverse impact on operations.

Accounts Receivable:

As of December 31, 2013, the Company had two customers, Amazon.com and Costco, that represented 62.3% and 23.6% of the Company’s outstanding accounts receivable, respectively.  As of March 31, 2013, the Company one customer, Amazon.com  who represented 61.2% of outstanding accounts receivable.  The Company believes that all receivables from these customers are collectible.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments

The Company follows the guidance in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), as it relates to the fair value of its financial assets and liabilities. ASC 820 provides for a standard definition of fair value to be used in new and existing pronouncements. This guidance requires disclosure of fair value information about certain financial instruments (insurance contracts, real estate, goodwill and taxes are excluded) for which it is practicable to estimate such values, whether or not these instruments are included in the balance sheet at fair value. The fair values presented for certain financial instruments are estimates which, in many cases, may differ significantly from the amounts that could be realized upon immediate liquidation.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability, i.e., exit price, in an orderly transaction between market participants.  ASC 820 also provides a hierarchy for determining fair value, which emphasizes the use of observable market data whenever available. The three broad levels defined by the hierarchy are as follows, with the highest priority given to Level 1 as these are the most reliable, and the lowest priority given to Level 3.

Level 1 – Quoted prices in active markets for identical assets.

Level 2 – Quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, or other inputs that are observable or can be corroborated by observable market data, including model-derived valuations.

Level 3 – Unobservable inputs that are supported by little or no market activity.

The carrying value of financial instruments including receivables and accounts payable, approximates their fair value at December 31, 2013 and March 31, 2013 due to the relatively short-term nature of these instruments. As of December 31, 2013 and March 31, 2013, the fair value of the Company's debt, notes payable, and sale of intellectual property liability using Level 3 inputs was estimated using the discounted cash flow method, which is based on the future expected cash flows, discounted to their present values, using a discount rate of 15%.

In conjunction with a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with the subsidiary, “Scotts Miracle-Gro”) on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock. This warrant was accounted for as a liability at its estimated fair value. The Company calculated the fair value of the warrant during the quarter ended December 31, 2013 using a multiple based valuation model.  As of December 31, 2013, the Company measured the warrant at fair value and will continue to do so on a quarterly basis.  As of March 31, 2013, the Company did not have any financial assets or liabilities that were measured at fair value on a recurring basis subsequent to initial recognition.

Receivables, Policy [Policy Text Block]

Accounts Receivable and Allowance for Doubtful Accounts

The Company sells its products to retailers and consumers. Consumer transactions are primarily paid by credit card.  Retailer sales terms vary by customer, but generally range from net 30 days to net 60 days.  Accounts receivable are reported at net realizable value and net of the allowance for doubtful accounts. The Company uses the allowance method to account for uncollectible accounts receivable. The Company's allowance estimate is based on a review of the current status of trade accounts receivable, which resulted in an allowance of $13,000 and $1,000 at December 31, 2013 and March 31, 2013, respectively.

Other Receivables

In conjunction with the Company’s processing of credit card transactions for its direct-to-consumer sales activities and as security with respect to the Company’s performance for credit card refunds and charge backs, the Company is required to maintain a cash reserve with Litle and Company, the Company’s credit card processor. This reserve is equal to 5% of the credit card sales processed during the previous six months. As of December 31, 2013 and March 31, 2013, the balance in this reserve account was $131,000 and $169,000, respectively.

Advertising Costs, Policy [Policy Text Block]

Advertising and Production Costs

The Company expenses all production costs related to advertising, including print, television, and radio advertisements when the advertisement has been broadcast or otherwise distributed.  The Company records media costs related to its direct-to-consumer advertisements, inclusive of postage and printing costs incurred in conjunction with mailings of direct-response catalogues, and related direct-response advertising costs, in accordance with ASC 340-20-Reporting on Advertising Costs.  As prescribed by ASC 340-20-25, direct-to-consumer advertising costs incurred are reported as assets and are amortized over the estimated period of the benefits, based on the proportion of current period revenue from the advertisement to probable future revenue.  

As the Company has re-entered the retail distribution channel, the Company has expanded its advertising to online gateway and portal advertising, as well as placement in third party catalogues.

Advertising expense for the three and nine months ended December 31, 2013 and December 31, 2012, were as follows:

	Three Months Ended December 31, (in thousands)				Nine Months Ended December 31, (in thousands)
	2013		2012		2013		2012
Direct-to-consumer	$	391	$	534	$	506	$	825
Retail		390		1		393		1
Total advertising expense	$	781	$	535	$	899	$	826

As of December 31, 2013 and March 31, 2013, the Company deferred $6,000 and $4,000, respectively, related to such media and advertising costs.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Deferred advertising and media	$	6	$	4

Inventory

Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at cost.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Finished goods	$	1,124	$	606
Raw materials		474		623
	$	1,598	$	1,229

Inventory, Policy [Policy Text Block]

Inventory

Inventories are valued at the lower of cost, determined by the first-in, first-out method, or market.  Included in inventory costs where the Company is the manufacturer are raw materials, labor, and manufacturing overhead. The Company records the raw materials at delivered cost. Standard labor and manufacturing overhead costs are applied to the finished goods based on normal production capacity.  A majority of the Company’s products are manufactured overseas and are recorded at cost.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Finished goods	$	1,124	$	606
Raw materials		474		623
	$	1,598	$	1,229

The Company determines an inventory obsolescence reserve based on management’s historical experience and establishes reserves against inventory according to the age of the product. As of December 31, 2013 and March 31, 2013, the Company had reserved $332,000 for inventory obsolescence.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

The Company recognizes revenue from product sales, net of estimated returns, when persuasive evidence of a sale exists: that is, a product is shipped under an agreement with a customer; risk of loss and title has passed to the customer; the fee is fixed or determinable; and collection of the resulting receivable is reasonably assured.

The Company records estimated reductions to revenue for customer and distributor programs and incentive offerings, including promotions, rebates, and other volume-based incentives.  Certain incentive programs require the Company to estimate based on industry experience the number of customers who will actually redeem the incentive. As of December 31, 2013 and March 31, 2013, the Company had accrued $236,000 and $43,000, respectively, as its estimate for the foregoing deductions and allowances.

Standard Product Warranty, Policy [Policy Text Block]

Warranty and Return Reserves

The Company records warranty liabilities at the time of sale for the estimated costs that may be incurred under its basic warranty program. The specific warranty terms and conditions vary depending upon the product sold, but generally include technical support, repair parts, and labor for periods up to one year. Factors that affect the Company’s warranty liability include the number of installed units currently under warranty, historical and anticipated rates of warranty claims on those units, and cost per claim to satisfy the Company’s warranty obligation.  Based upon the foregoing, the Company has recorded a reserve for potential future warranty costs of $14,000 and $10,000 as of December 31, 2013 and March 31, 2013, respectively.

The Company reserves for known and potential returns from customers and associated refunds or credits related to such returns based upon historical experience. In certain cases, retailer customers are provided a fixed allowance, usually in the 1% to 2% range, to cover returned goods and this allowance is deducted from payments made to us by such customers. As of December 31, 2013 and March 31, 2013, the Company has recorded a reserve for customer returns of $80,000 and $27,000, respectively.

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued Accounting Pronouncements

In July 2013, the FASB issued ASU 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,” which among other things, requires an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as denoted within the ASU. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. This new guidance will not have a material impact on our financial statements.

XML

8. Stockholders' Equity

9 Months Ended

Dec. 31, 2013

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

8.    Stockholders’ Equity

On October 17, 2012, a 1-for-100 reverse stock split of AeroGrow’s common stock became effective.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock.  All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.

A summary of the Company’s common stock warrant activity for the period from April 1, 2013 through December 31, 2013 is presented below:

	Warrants Outstanding (in thousands)		Weighted Average Exercise Price		Aggregate Intrinsic Value
Outstanding, April 1, 2013		528	$	22.41	$	0.00
Granted		175		1.70
Exercised		-		-
Expired		0		0.98
Outstanding, December 31, 2013		703	$	17.22	$	0.00

As of December 31, 2013, the Company had the following outstanding warrants to purchase its common stock:

		Weighted Average
Warrants Outstanding (in thousands)		Exercise Price		Remaining Life (years)
	125	$	1.54		4.31
	50	$	2.10		4.77
	394	$	7.00		3.28
	122	$	20.00		1.37
	1	$	25.00		0.77
	3	$	100.00		0.13
	7	$	800.00		0.68
	1	$	825.00		0.68
	703	$	17.22		3.19

As discussed further in Note 4, the Company also issued a warrant that entitles, but not obligate Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company’s outstanding capital stock.

XML

9. Subsequent Events

9 Months Ended

Dec. 31, 2013

Subsequent Events [Abstract]

Subsequent Events [Text Block]

9.    Subsequent Events

None

XML

2. Liquidity and Basis of Presentation (Tables)

9 Months Ended

Dec. 31, 2013

Disclosure Text Block [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table presents the computation of basic and diluted net income per share for the three months ended December 31, 2013 (in thousands, except per share amounts):

	December 31, 2013
Net income available to common shareholders	$	76
Basic:
Weighted-average shares outstanding		5,906
Basic net income per share	$	0.01
Diluted:
Weighted-average shares outstanding		5,906
Add: Dilutive potential shares-Stock options		86
Weighted-average shares used in computing diluted net income per share		5,992
Diluted net income per share	$	0.01

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	December 31, 2013 (in thousands)				March 31, 2013 (in thousands)
	Fair Value		Carry Value		Fair Value		Carry Value
Liabilities
Notes payable	$	-	$	-	$	610	$	641
Sale of intellectual property liability		178		271		-		-
Derivative warrant liability		595		595		-		-
Long-term debt		109		112		1,726		2,068
Total	$	882	$	978	$	2,336	$	2,709

Schedule of Other Operating Cost and Expense, by Component [Table Text Block]

Advertising expense for the three and nine months ended December 31, 2013 and December 31, 2012, were as follows:

	Three Months Ended December 31, (in thousands)				Nine Months Ended December 31, (in thousands)
	2013		2012		2013		2012
Direct-to-consumer	$	391	$	534	$	506	$	825
Retail		390		1		393		1
Total advertising expense	$	781	$	535	$	899	$	826

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]

As of December 31, 2013 and March 31, 2013, the Company deferred $6,000 and $4,000, respectively, related to such media and advertising costs.

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Deferred advertising and media	$	6	$	4

Schedule of Inventory, Current [Table Text Block]

	December 31,		March 31,
	2013 (in thousands)		2013 (in thousands)
Finished goods	$	1,124	$	606
Raw materials		474		623
	$	1,598	$	1,229

XML

8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding (USD $) In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	703
Weighted Average Exercise Price (in Dollars per share)	$ 17.22
Weighted Average Remaing Life (Yrs)	3 years 69 days
Warrants exercisable at $1.54 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	125
Weighted Average Exercise Price (in Dollars per share)	$ 1.54
Weighted Average Remaing Life (Yrs)	4 years 113 days
Warrants Exercisable at $2.10 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	50
Weighted Average Exercise Price (in Dollars per share)	$ 2.10
Weighted Average Remaing Life (Yrs)	4 years 281 days
Warrants Exercisable at $7.00 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	394
Weighted Average Exercise Price (in Dollars per share)	$ 7.00
Weighted Average Remaing Life (Yrs)	3 years 102 days
Warrants exercisable at $20.00 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	122
Weighted Average Exercise Price (in Dollars per share)	$ 20.00
Weighted Average Remaing Life (Yrs)	1 year 135 days
Warrants Exercisable at $25.00 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	1
Weighted Average Exercise Price (in Dollars per share)	$ 25.00
Weighted Average Remaing Life (Yrs)	281 days
Warrants exercisable at $100.00 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	3
Weighted Average Exercise Price (in Dollars per share)	$ 100.00
Weighted Average Remaing Life (Yrs)	47 days
Warrants exercisable at $800.00 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	7
Weighted Average Exercise Price (in Dollars per share)	$ 800.00
Weighted Average Remaing Life (Yrs)	248 days
Warrants exercisable at $825.00 [Member]
8. Stockholders' Equity (Details) - Schedule of Warrants Outstanding [Line Items]
Warrants Outstanding	1
Weighted Average Exercise Price (in Dollars per share)	$ 825.00
Weighted Average Remaing Life (Yrs)	248 days

XML

2. Liquidity and Basis of Presentation (Details) - Schedule of Earnings Per Share, Basic and Diluted (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Schedule of Earnings Per Share, Basic and Diluted [Abstract]
Net income available to common shareholders (in Dollars)	$ 76	$ (297)	$ (881)	$ (7,863)
Basic:
Weighted-average shares outstanding	5,906	5,905	5,905	5,826
Basic net income per share (in Dollars per share)	$ 0.01	$ (0.05)	$ (0.10)	$ (1.35)
Diluted:
Weighted-average shares outstanding	5,906	5,905	5,905	5,826
Add: Dilutive potential shares-Stock options	86
Weighted-average shares used in computing diluted net income per share	5,992	5,905	5,905	5,826
Diluted net income per share (in Dollars per share)	$ 0.01	$ (0.05)	$ (0.10)	$ (1.35)

XML

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) (USD $)	9 Months Ended			12 Months Ended				9 Months Ended		9 Months Ended		12 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Mar. 31, 2013 Investor [Member] 2012 Credit Card Receipts [Member]	Mar. 31, 2013 Company-Referred Investors [Member] 2012 Credit Card Receipts [Member]	Mar. 31, 2013 Directors and Officers [Member] 2012 Credit Card Receipts [Member]	Mar. 31, 2013 Issued to Placement Agent [Member] 2012 Credit Card Receipts [Member]	Dec. 31, 2013 Main Power Promissory Note [Member]	Mar. 31, 2013 Main Power Promissory Note [Member]	Dec. 31, 2013 First Western Trust Term Loan [Member]	Mar. 31, 2013 First Western Trust Term Loan [Member]	Mar. 31, 2013 2012 Credit Card Receipts [Member]	Mar. 31, 2013 2011 Credit Card Receipts-Backed Notes [Member]	Dec. 31, 2013 Pawnee Promissory Note [Member]	Mar. 31, 2013 Pawnee Promissory Note [Member]	Dec. 31, 2013 Scotts Miracle-Gro Company [Member]
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) [Line Items]
Debt Instrument, Face Amount								$ 1,400,000		$ 1,000,000		$ 1,300,000		$ 116,000
Debt Instrument, Maturity Date, Description								extend the payment schedule, maturity date and
Repayments of Long-term Debt	1,243,000	251,000						950,000
Inventory Valuation Reserves	332,000		332,000					237,000
Gains (Losses) on Extinguishment of Debt	489,000	0						489,000
Debt Instrument, Collateral										secured by a lien on our assets		backed by a portion of the Company's prospective credit card receipts, (the "2012 Credit Card Notes") and 128,573 shares of common stock (collectively, the "2012 Credit Card Offering")
Debt Instrument, Interest Rate, Stated Percentage										7.25%		15.00%
Debt Instrument, Payment Terms										equal monthly payments of principal/interest over the four-year term of the FWTB Term
Debt Instrument, Maturity Date										May 21, 2014
Long-term Debt	978,000		2,709,000					0	1,704,000	99,000	323,000			13,000	42,000
Debt, consideration												comprised $1.3 million in cash
Debt Related Commitment Fees and Debt Issuance Costs												46,000
Debt, sales commission percentage				5.00%	3.00%	0.00%
Proceeds from Debt, Net of Issuance Costs												1,200,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in Shares)							12,858
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award							one share of common stock for every 10 shares issued to investors
Repayments of Debt (in Dollars)								950,000					198,000
Debt Instrument, Interest Rate Terms														carries an interest rate of 6% per annum for the first twelve months, and 8% per annum thereafter
Derivative Liability, Current	595,000															595,000
Debt, Current	$ 271,000		$ 0													$ 271,000

XML

CONDENSED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net (loss)	$ (246)	$ (7,863)
Adjustments to reconcile net (loss) to cash (used) provided by operations:
Issuance of common stock and options under equity compensation plans	176	167
Issuance of common stock warrants	18	0
Depreciation and amortization expense	113	123
Bad debt expense	13	2
Fair value remeasurement of derivative warrant liability	31	0
Accretion of debt associated with sale of intellectual property	(35)	0
Gain on the forgiveness of debt	(489)	0
Debt conversion costs associated with inducement	0	3,462
Amortization of debt issuance costs	16	988
Amortization of convertible debentures, beneficial conversion feature	0	1,067
Amortization of convertible debentures, beneficial conversion feature – related party	0	189
Interest expense from warrants issued with convertible debentures	0	955
Interest expense from warrants issued with convertible debentures – related party	0	187
Change in operating assets and liabilities:
(Increase) in accounts receivable	(1,313)	(271)
Decrease in other receivable	38	52
(Increase) in inventory	(606)	(182)
(Increase) decrease in other current assets	(18)	151
Increase in accounts payable	377	72
Increase in accrued expenses	517	148
Increase in accrued interest	49	116
Increase in accrued interest-related party	8	22
(Decrease) increase in customer deposits	(157)	149
(Decrease) in deferred rent	(2)	0
Net cash (used) provided by operating activities	(1,510)	(466)
Cash flows from investing activities:
Decrease in restricted cash	27	1
Purchases of equipment	(184)	(292)
Patent expenses	0	(10)
Proceeds from the sale of intellectual property	500	0
Net cash provided (used) by investing activities	343	(301)
Cash flows from financing activities:
(Increase) in prepaid debt issuance costs	0	(46)
Proceeds from notes payable, net	0	1,041
Proceeds from notes payable – related party, net	0	245
Repayments of notes payable	(563)	(796)
Repayments of notes payable – related party	(123)	(272)
Repayments of long term debt borrowings	(1,243)	(251)
Proceeds from the exercise of stock options	2	0
Proceeds from the issuance of preferred stock	4,000	0
Payments for offering costs of preferred stock	(157)	0
Proceeds from the exercise and issuance of warrants	0	1,181
Net cash provided by financing activities	1,916	1,102
Net increase in cash	749	335
Cash, beginning of period	525	502
Cash, end of period	1,274	837
Interest	41	119
Income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Deemed dividend on convertible preferred stock	268	0
Decrease of inventory associated with debt settlement	237	0
Fair value of derivative warrant liability	564	0
Fair value of warrant issue to placement agent	108	0
Debt associated with sale of intellectual property	297	0
Dividends accrued on convertible preferred stock	367	0
Decrease of debt associated with inventory consumption	0	242
Issuance of common stock in accordance with credit card note	0	177
Conversion of accrued expenses to common stock	0	28
Conversion of Note Payable to Common Stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Debt to Common Stock	0	212
Conversion of Note Payable - Related Party to Common Stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Debt to Common Stock	0	129
Conversion of convertible note to common stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Debt to Common Stock	0	5,718
Conversion of convertible note accrued interest to common stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Debt to Common Stock	0	545
Conversion of convertible note-related party to common stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Debt to Common Stock	0	1,079
Conversion of convertible note-related party accrued interest to common stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Debt to Common Stock	$ 0	$ 103

XML

5. Equity Compensation Plans

9 Months Ended

Dec. 31, 2013

Share-based Arrangements with Employees and Nonemployees [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

5.    Equity Compensation Plans

On October 17, 2012, the Company implemented a 1-for-100 reverse stock split of its common stock that had previously been approved by stockholders.  As a result of the reverse stock split, every 100 shares of AeroGrow’s pre-reverse common stock were converted automatically into one share of common stock. All references below to shares of common stock, common stock warrants, or common stock options have been adjusted to reflect the reverse stock split.

For the three months ended December 31, 2013, the Company granted 180,000 options to purchase the Company’s common stock under the Company’s 2005 Equity Compensation Plan (the “2005 Plan”).  For the nine months ended December 31, 2013, the Company granted options to purchase 331,000 options to purchase the Company’s common stock under the 2005 Plan.  For the three and nine months ended December 31, 2012, the Company did not grant any options to purchase the Company’s common stock under the 2005 Plan.

During the three months ended December 31, 2013, options to purchase 75,000 shares of common stock were cancelled or expired, and 2,000 shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the three months ended December 31, 2012, options to purchase 1,000 shares of common stock were cancelled or expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.

During the nine months ended December 31, 2013, options to purchase 109,000 shares of common stock were cancelled or expired, and 2,000 shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.  During the nine months ended December 31, 2012, options to purchase 1,000 shares of common stock were cancelled or expired, and no shares of common stock were issued upon exercise of outstanding stock options under the 2005 Plan.

As of December 31, 2013, the Company had granted options to purchase 274,000 shares of the Company’s common stock that are unvested and that will result in $316,000 of compensation expense in future periods if fully vested.  

Information regarding all stock options outstanding under the 2005 Plan as of December 31, 2013 is as follows:

		OPTIONS OUTSTANDING								OPTIONS EXERCISABLE
				Weighted-								Weighted-
				average		Weighted-		Aggregate				average		Weighted-		Aggregate
				Remaining		average		Intrinsic				Remaining		average		Intrinsic
Exercise		Options		Contractual		Exercise		Value		Options		Contractual		Exercise		Value
price		(in thousands)		Life (years)		Price		(in thousands)		(in thousands)		Life (years)		Price		(in thousands)
$	1.01		162		4.10	$	1.01				74		4.10	$	1.01
$	1.10		100		4.25	$	1.10				75		4.25	$	1.10
$	1.21		50		4.25	$	1.21				38		4.25	$	1.21
$	2.20		164		4.77	$	2.20				23		4.77	$	1.21
$	2.42		10		4.77	$	2.42				2		4.77	$	1.21
$	7.00		1		1.33	$	7.00				1		1.33	$	7.00
$	8.00		5		1.92	$	8.00				5		1.92	$	8.00
$	12.00		1		0.60	$	12.00				1		0.60	$	12.00
$	13.00		1		0.61	$	13.00				1		0.61	$	13.00
$	14.00		0		1.47	$	14.00				0		1.47	$	14.00
$	18.00		5		0.17	$	18.00				5		0.17	$	18.00
$	20.00		0		1.00	$	20.00				0		1.00	$	20.00
			499		4.30	$	1.77	$	497		225		4.07	$	1.88	$	271

The aggregate intrinsic value in the preceding table represents the difference between the Company’s closing stock price and the exercise price of each in-the-money option on the last trading day of the period presented, which was December 31, 2013.

XML

3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2013
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]
Long-Term Debt	$ 978	$ 2,709
Less notes payable and current portion – long term debt	978	1,540
Long term debt	0	1,169
Scotts Miracle-Gro Company [Member] | Sale of Intellectual Property Liability [Member]
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]
Long-Term Debt	271	0
Scotts Miracle-Gro Company [Member] | Derivative Warrant Liability [Member]
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]
Long-Term Debt	595	0
Main Power Promissory Note [Member]
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]
Long-Term Debt	0	1,704
First Western Trust Term Loan [Member]
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]
Long-Term Debt	99	323
Notes Payable - Credit Card Receipts Backed Notes [Member]
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]
Long-Term Debt	0	640
Pawnee Promissory Note [Member]
3. Notes Payable, Long Term Debt and Current Portion - Long Term Debt (Details) - Schedule of Debt [Line Items]
Long-Term Debt	$ 13	$ 42

XML

2. Liquidity and Basis of Presentation (Details) (USD $) Share data in Millions, unless otherwise specified	9 Months Ended		3 Months Ended		9 Months Ended			3 Months Ended		9 Months Ended					3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended			3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended			12 Months Ended
	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2013 Major Customer 1 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2012 Major Customer 1 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2013 Major Customer 1 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2012 Major Customer 1 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2013 Major Customer 1 [Member] Credit Concentration Risk [Member] Accounts Receivable [Member]	Dec. 31, 2013 Major Customer 2 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2012 Major Customer 2 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2013 Major Customer 2 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2012 Major Customer 2 [Member] Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2013 Major Customer 2 [Member] Credit Concentration Risk [Member] Accounts Receivable [Member]	Dec. 31, 2013 Equity Option [Member]	Dec. 31, 2013 Warrant [Member]	Dec. 31, 2013 Major Supplier 1 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Major Supplier 1 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Major Supplier 1 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Major Supplier 1 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Major Supplier 2 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Major Supplier 2 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Major Supplier 2 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Major Supplier 2 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Major Supplier 3 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Major Supplier 3 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Major Supplier 3 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Major Supplier 4 [Member] Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2012 Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2013 Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2012 Customer Concentration Risk [Member] Sales [Member]	Dec. 31, 2013 Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2012 Supplier Concentration Risk [Member] Cost of Goods, Total [Member]	Dec. 31, 2013 Credit Concentration Risk [Member] Accounts Receivable [Member]	Mar. 31, 2013 Credit Concentration Risk [Member] Accounts Receivable [Member]	Dec. 31, 2013 Allowance for Sales Returns [Member]	Mar. 31, 2013 Allowance for Sales Returns [Member]
2. Liquidity and Basis of Presentation (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)													13,000	528,000
Number of financial institutions with deposits in excess of federally insured limit	1
Cash, FDIC Insured Amount	$ 250,000
Concentration Risk, Customer																											two customers	two customers	two customers	two customers					two customers	one customer
Concentration Risk, Percentage			39.20%	19.30%	33.60%	10.40%	62.30%	10.70%	12.80%	7.90%	7.90%	23.60%			29.30%	15.80%	34.40%	20.20%	24.70%	15.30%	24.90%	14.90%	7.20%	6.80%	13.50%	11.50%										61.20%
Concentration Risk, Supplier																															three suppliers	two suppliers	three suppliers	four suppliers
Cost of Goods Sold															839,000	263,000	1,400,000	587,000	707,000	254,000	992,000	433,000	205,000	270,000	392,000	334,000
Fair Value Inputs, Discount Rate	15.00%
Security Purchase Agreement, Description	a Securities Purchase Agreement and strategic alliance with a wholly owned subsidiary of The Scotts Miracle-Gro Company (collectively with the subsidiary, "Scotts Miracle-Gro") on April 22, 2013, the Company issued a warrant that entitles, but does not obligate, Scotts Miracle-Gro to purchase a number of shares of common stock that, on a fully diluted basis, constitute 80% of the Company's outstanding capital stock.
Allowance for Doubtful Accounts Receivable, Current	13,000	1,000
Other receivable, reserve percentage of credit card sales	5.00%
Deposits Assets, Current	131,000	169,000
Deferred Advertising Costs	6,000	4,000
Inventory Valuation Reserves	332,000	332,000
Other Accrued Liabilities	236,000	43,000
Provision for Future Warranty Costs	14,000	10,000
Customer Refund Liability, Current																																					$ 80,000	$ 27,000